<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Nutrients</journal-id>
<journal-id journal-id-type="iso-abbrev">Nutrients</journal-id>
<journal-id journal-id-type="publisher-id">nutrients</journal-id>
<journal-title-group>
<journal-title>Nutrients</journal-title>
</journal-title-group>
<issn pub-type="epub">2072-6643</issn>
<publisher>
<publisher-name>MDPI</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32752078</article-id>
<article-id pub-id-type="pmc">7468823</article-id>
<article-id pub-id-type="doi">10.3390/nu12082311</article-id>
<article-id pub-id-type="publisher-id">nutrients-12-02311</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>How 25(OH)D Levels during Pregnancy Affect Prevalence of Autism in Children: Systematic Review</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Uçar</surname>
<given-names>Nazlı</given-names>
</name>
<xref ref-type="aff" rid="af1-nutrients-12-02311">1</xref>
<xref ref-type="aff" rid="af2-nutrients-12-02311">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1439-3285</contrib-id>
<name>
<surname>Grant</surname>
<given-names>William B.</given-names>
</name>
<xref ref-type="aff" rid="af3-nutrients-12-02311">3</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4148-6161</contrib-id>
<name>
<surname>Peraita-Costa</surname>
<given-names>Isabel</given-names>
</name>
<xref ref-type="aff" rid="af2-nutrients-12-02311">2</xref>
<xref ref-type="aff" rid="af4-nutrients-12-02311">4</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0785-1492</contrib-id>
<name>
<surname>Morales Suárez-Varela</surname>
<given-names>María</given-names>
</name>
<xref ref-type="aff" rid="af2-nutrients-12-02311">2</xref>
<xref ref-type="aff" rid="af4-nutrients-12-02311">4</xref>
<xref ref-type="corresp" rid="c1-nutrients-12-02311">*</xref>
</contrib>
</contrib-group>
<aff id="af1-nutrients-12-02311"><label>1</label>Department of Nutrition and Dietetics, Faculty of Health Sciences, Acıbadem University, İçerenköy, Kayışdağı Cd. No:32, Ataşehir/İstanbul 34684, Turkey; <email>nazli.ucar.94@gmail.com</email></aff>
<aff id="af2-nutrients-12-02311"><label>2</label>Area of Preventive Medicine and Public Health, Department of Preventive Medicine and Public Health, Food Sciences, Toxicology and Legal Medicine, School of Pharmacy, University de Valencia, Avenida Vicent Andres Estelles s/n, 46100 Valencia, Spain; <email>ipecos@alumni.uv.es</email></aff>
<aff id="af3-nutrients-12-02311"><label>3</label>Sunlight, Nutrition, and Health Research Center, P.O. Box 641603, San Francisco, CA 94164-1603, USA; <email>wbgrant@infionline.net</email></aff>
<aff id="af4-nutrients-12-02311"><label>4</label>Biomedical Research Center Network on Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Avenida Monforte de Lemos, 3-5, Pabellón 11, Planta 0, 28029 Madrid, Spain</aff>
<author-notes>
<corresp id="c1-nutrients-12-02311"><label>*</label>Correspondence: <email>maria.m.morales@uv.es</email>; Tel.: +34-96-3544951</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>31</day>
<month>7</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<month>8</month>
<year>2020</year>
</pub-date>
<volume>12</volume>
<issue>8</issue>
<elocation-id>2311</elocation-id>
<history>
<date date-type="received">
<day>23</day>
<month>6</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>7</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>© 2020 by the authors.</copyright-statement>
<copyright-year>2020</copyright-year>
<license license-type="open-access">
<license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>Autism spectrum disorder (ASD) is a group of dysfunctions in social interaction, communication, and behaviors. The etiology of ASD is not yet fully understood; however, it consists of the interaction between genetics and the environment. An increasing amount of evidence points to the possibility that gestational and early-childhood vitamin D deficiency may be involved in the etiology of some cases of ASD. Herein, we systematically review the literature for studies on vitamin D status during pregnancy and ASD outcomes. Forty-three studies in the PubMed and 124 studies in EMBASE databases were initially found. After screening, 26 were identified as candidate studies for inclusion. Finally, 14 articles met the inclusion criteria, which originated from nine countries. The studies included 10 original research studies and four review studies conducted between 2012 and 2020. The strength of evidence that vitamin D levels during pregnancy increase the risk of developing autism is very low. This is because the evidence relies exclusively on observational studies that did not equally consider all important confounders and that assessed the indirect relationship between vitamin D as a surrogate for sunlight exposure and autism risk. The findings of this systematic review are consistent with the hypothesis that low vitamin D levels might contribute to the development of autism. However, we must also recognize the possible confusion bias and therefore experimental studies with very large sample sizes, given incidence of autism, that allow us to detect blood levels in pregnant women would be helpful to clarify this point.</p>
</abstract>
<kwd-group>
<kwd>hedging</kwd>
<kwd>transaction costs</kwd>
<kwd>dynamic programming</kwd>
<kwd>risk management</kwd>
<kwd>post-decision state variable</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-nutrients-12-02311" sec-type="intro">
<title>1. Introduction</title>
<p>As described in the DSM-V, autism spectrum disorder (ASD) is a heterogeneous neurodevelopmental condition affecting an individual’s ability to socialize and communicate [<xref ref-type="bibr" rid="B1-nutrients-12-02311">1</xref>]. ASD often presents with repetitive movements or behaviors, restricted interests, and abnormality in sensory processing [<xref ref-type="bibr" rid="B2-nutrients-12-02311">2</xref>]. The prevalence of ASD has risen dramatically over the last several decades, from 1 in 5000 children in 1975 to 1 in 45 children in 2014 in the United States. That trend shows a 700% increase within 40 years [<xref ref-type="bibr" rid="B3-nutrients-12-02311">3</xref>]. However, the cause of that rapid growth is not fully known. True increase in incidence of autism cannot be ruled out and constitutes an “urgent public health concern” [<xref ref-type="bibr" rid="B4-nutrients-12-02311">4</xref>,<xref ref-type="bibr" rid="B5-nutrients-12-02311">5</xref>]. Despite considerable effort to determine the etiological factors of ASD, no single or definitive cause has been identified [<xref ref-type="bibr" rid="B6-nutrients-12-02311">6</xref>]. The etiology of ASD is unknown, although the interaction of genetic and environmental factors is believed to play a fundamental role in the process [<xref ref-type="bibr" rid="B7-nutrients-12-02311">7</xref>]. Biological factors possibly associated with autism risk include hereditary risk factors [<xref ref-type="bibr" rid="B8-nutrients-12-02311">8</xref>]. Despite early evidence of heredity of autism, the largest population-based study of twins with autism is that adaptation rates for fraternal twins are higher than previously reported and that the shared prenatal environment constitutes a greater proportion of the risk of autism in twins [<xref ref-type="bibr" rid="B9-nutrients-12-02311">9</xref>,<xref ref-type="bibr" rid="B10-nutrients-12-02311">10</xref>,<xref ref-type="bibr" rid="B11-nutrients-12-02311">11</xref>]. ASD has been tentatively associated with &gt;440 identified gene variants. Of those cases that can be clearly linked to genetic causes, 7–20% can be accounted for by copy number variants, 5–7% are attributed to single-nucleotide polymorphisms, and &lt;5% are linked to genes involved in rare metabolic disorders [<xref ref-type="bibr" rid="B12-nutrients-12-02311">12</xref>]. Thus, nearly 70% of cases have a cause that has not been linked to genetics [<xref ref-type="bibr" rid="B10-nutrients-12-02311">10</xref>]. Lifestyle and environmental factors such as nutrition [<xref ref-type="bibr" rid="B13-nutrients-12-02311">13</xref>,<xref ref-type="bibr" rid="B14-nutrients-12-02311">14</xref>], toxic substances [<xref ref-type="bibr" rid="B15-nutrients-12-02311">15</xref>,<xref ref-type="bibr" rid="B16-nutrients-12-02311">16</xref>], medications [<xref ref-type="bibr" rid="B17-nutrients-12-02311">17</xref>,<xref ref-type="bibr" rid="B18-nutrients-12-02311">18</xref>], maternal infections during pregnancy [<xref ref-type="bibr" rid="B19-nutrients-12-02311">19</xref>,<xref ref-type="bibr" rid="B20-nutrients-12-02311">20</xref>], vaccine immunization [<xref ref-type="bibr" rid="B21-nutrients-12-02311">21</xref>], and stress [<xref ref-type="bibr" rid="B22-nutrients-12-02311">22</xref>] have been extensively studied. In particular, the factors that cause autism—air pollution, cloudy weather, seasonal factors, migration of dark-skinned immigrants to poleward latitudes, birth order, gestational diabetes, preeclampsia, cesarean delivery, autoimmune disease in the family, and nutrition—are all associated with vitamin D [<xref ref-type="bibr" rid="B23-nutrients-12-02311">23</xref>,<xref ref-type="bibr" rid="B24-nutrients-12-02311">24</xref>]. To give an example through studies, gestational vitamin D deficiency was associated with a 2.66-fold higher risk in developing gestational diabetes [<xref ref-type="bibr" rid="B25-nutrients-12-02311">25</xref>] and in utero exposure to gestational diabetes mellitus, giving the child a 4.4 adjusted odds ratio (aOR) for ASD [<xref ref-type="bibr" rid="B26-nutrients-12-02311">26</xref>]. Birth via cesarean delivery increases the risk of autism [<xref ref-type="bibr" rid="B27-nutrients-12-02311">27</xref>], and low maternal vitamin D increases the risk of having to give birth via C-sections up to fourfold [<xref ref-type="bibr" rid="B28-nutrients-12-02311">28</xref>]. A 2009 study in <italic>Dermato-Endocrinology</italic> examined whether maternal vitamin D deficiency is a risk factor for infantile autism disease (IAD) [<xref ref-type="bibr" rid="B29-nutrients-12-02311">29</xref>]. In the study using epidemiological data on seasonal variation of birth rates and prevalence of IAD for cohorts born before 1985, the researchers found a strong effective latitudinal (related to wintertime solar UVB radiation) increase in IAD prevalence. Those findings are consistent with the hypothesis that maternal vitamin D deficiency is a risk factor for IAD. Another study examined ASD trends by considering birth data in Denmark, Finland, Norway, Sweden, and Western Australia [<xref ref-type="bibr" rid="B30-nutrients-12-02311">30</xref>]. The data showed a modest increase in risk for children born in the fall and a modest decrease for children born in the spring. The researchers concluded that the risk was highest for fall births and lowest for spring births, and sunlight levels during critical neurodevelopmental periods explained much of the seasonal trends and are consistent with the hypothesis that a seasonally fluctuating risk factor may influence risk of ASD. In line with several previous studies, an association was apparent between ASD and season of births [<xref ref-type="bibr" rid="B31-nutrients-12-02311">31</xref>,<xref ref-type="bibr" rid="B32-nutrients-12-02311">32</xref>,<xref ref-type="bibr" rid="B33-nutrients-12-02311">33</xref>,<xref ref-type="bibr" rid="B34-nutrients-12-02311">34</xref>,<xref ref-type="bibr" rid="B35-nutrients-12-02311">35</xref>]. Moreover, a 2013 ecological study reported that autism prevalence among those aged 6–17 y in 2010 was significantly inversely correlated with solar UVB doses [<xref ref-type="bibr" rid="B36-nutrients-12-02311">36</xref>]. Those results add to the evidence that vitamin D deficiency may be an important risk factor for autism. In 2008, Cannell proposed the autism–vitamin D theory [<xref ref-type="bibr" rid="B37-nutrients-12-02311">37</xref>], in which the primary environmental trigger for autism is the lack of vitamin D in pregnancy and early childhood.</p>
<p>Vitamin D metabolism and homeostasis during pregnancy is significantly different than that found outside of pregnancy in order to meet the demands of an optimal intrauterine environment for correct embryonic development and a successful, uncomplicated delivery as well as the immune regulation of the pregnancy [<xref ref-type="bibr" rid="B38-nutrients-12-02311">38</xref>,<xref ref-type="bibr" rid="B39-nutrients-12-02311">39</xref>,<xref ref-type="bibr" rid="B40-nutrients-12-02311">40</xref>]. Pregnancy is characterized by three major adaptations in vitamin D homeostasis that can be seen at both the systemic circulation and placental level; an increase in maternal calcitriol levels, changes in maternal 25(OH)D availability which an affect neonatal 25(OH)D status, and an increase of maternal vitamin D-binding protein concentrations [<xref ref-type="bibr" rid="B39-nutrients-12-02311">39</xref>]. Calcitriol increases by 2/3 times in the first weeks of pregnancy whereas maternal 25(OH)D crosses the placental barrier and represents the main pool of vitamin D in the fetus and maternal hypovitaminosis D during pregnancy may result in impaired neonatal 25(OH)D status at birth [<xref ref-type="bibr" rid="B39-nutrients-12-02311">39</xref>]. A limited number of studies have shown changes of vitamin D-binding protein concentrations during pregnancy, with highest concentrations reaching a 40–50% increase compared to non-pregnant women and with levels peaking at the beginning of the third trimester before starting to decrease at term [<xref ref-type="bibr" rid="B39-nutrients-12-02311">39</xref>]. In regard to immune regulation, the need for immunological tolerance of the mother towards the fetus is a key factor in the changes in vitamin D metabolism that appear during pregnancy [<xref ref-type="bibr" rid="B39-nutrients-12-02311">39</xref>]. During pregnancy, vitamin D receptor and regulatory metabolic enzymes are expressed in the placenta and decidua, indicating a potential critical point in the immunomodulation at the maternal–fetal interface [<xref ref-type="bibr" rid="B39-nutrients-12-02311">39</xref>]. Considering these effects, maternal hypovitaminosis D during pregnancy has been associated with pregnancy related disorders and adverse pregnancy outcomes [<xref ref-type="bibr" rid="B39-nutrients-12-02311">39</xref>].</p>
<p>In recent years, evidence has linked a lack of vitamin D not only to its known effects on calcium and bone metabolism but also to neurocognitive decline [<xref ref-type="bibr" rid="B41-nutrients-12-02311">41</xref>]. Adequate intake of vitamin D appears essential to global physical and mental health, as suggested by evidence that vitamin D deficiency can be associated with several diseases, such as infections, asthma, inflammatory bowel diseases, obesity, metabolic syndrome, and neuropsychiatric manifestations, including ASD [<xref ref-type="bibr" rid="B42-nutrients-12-02311">42</xref>]. About 90% of vitamin D is produced in the epidermis from 7-dehydrocholesterol as a reaction to sunlight (solar UVB radiation; 290–315 nm) [<xref ref-type="bibr" rid="B43-nutrients-12-02311">43</xref>]. Factors that limit the cutaneous production of vitamin D<sub>3</sub> include higher latitude, covering of skin, lack of outdoor activities, sunscreen use, old age, female sex, and darker skin pigmentation [<xref ref-type="bibr" rid="B44-nutrients-12-02311">44</xref>]. In an assessment derived from published studies, Holick and colleagues [<xref ref-type="bibr" rid="B43-nutrients-12-02311">43</xref>] estimated that due mainly to lack of sunlight exposure, approximately 1 billion people worldwide have inadequate vitamin D levels (as defined by level of 25-hydroxyvitamin D [25(OH)D], the primary circulating form of vitamin D in the serum, of &lt;75 nmol/L). In addition to sunlight, another important source of vitamin D is nutrition. People living in regions where sunlight is reduced, such as in northern Europe, need to include in their diets vitamin D-rich foods such as fatty fish or vitamin D-fortified foods [<xref ref-type="bibr" rid="B44-nutrients-12-02311">44</xref>].</p>
<p>Because it comes from solar UV radiation and exerts endocrine and autoendocrine effects, vitamin D is known as the sunshine hormone [<xref ref-type="bibr" rid="B45-nutrients-12-02311">45</xref>]. Therefore, the possible mechanisms of action of vitamin D, which is thought to have an important role in preventing and treating ASD, have been reviewed [<xref ref-type="bibr" rid="B46-nutrients-12-02311">46</xref>,<xref ref-type="bibr" rid="B47-nutrients-12-02311">47</xref>]. A 2015 study by Huang and colleagues [<xref ref-type="bibr" rid="B48-nutrients-12-02311">48</xref>] concluded that calcitriol (the active form of vitamin D<sub>3</sub>) can be used to alleviate neuroinflammation (caused mainly by oxidants and toxins). Another mechanism is vitamin D’s effect on serotonin through direct genetic regulation of serotonin rate-limiting enzymes, such as both peripheral tryptophan hydroxylase 1 (TPH1) and central TPH2 [<xref ref-type="bibr" rid="B49-nutrients-12-02311">49</xref>]. Activated vitamin D hormone (calcitriol) downregulates peripheral TPH1 while upregulating central TPH2, thus explaining the serotonin paradox in ASD in which peripheral serotonin is increased but central serotonin is reduced in those patients [<xref ref-type="bibr" rid="B49-nutrients-12-02311">49</xref>,<xref ref-type="bibr" rid="B50-nutrients-12-02311">50</xref>].</p>
<p>Calcitriol protects brain tissue by reducing inflammatory cytokine levels [<xref ref-type="bibr" rid="B51-nutrients-12-02311">51</xref>]. That increase is strongly associated with cognitive impairment in ASD [<xref ref-type="bibr" rid="B52-nutrients-12-02311">52</xref>]. Calcitriol also protects the brain by stimulating the production of neurotrophins from several sources. Neurotrophins are chemicals that fight toxic effects [<xref ref-type="bibr" rid="B53-nutrients-12-02311">53</xref>]. In fact, vitamin D taken orally is pro-prehormone. After ingestion, vitamin D is metabolized by the liver and converted to the 25(OH)D form and then forms calcitriol [(1,25(OH)<sub>2</sub>D]. Calcitriol is a powerful neurosteroid that assists in controlling brain cell growth and acts on vitamin D receptor molecules that appear in most brain cells during the first days of embryo formation [<xref ref-type="bibr" rid="B54-nutrients-12-02311">54</xref>].</p>
<p>Autistic individuals have abnormalities in immune functions similar to those affected by vitamin D deficiency, such as increased inflammatory cytokine levels [<xref ref-type="bibr" rid="B23-nutrients-12-02311">23</xref>]. Also, much of the ongoing inflammation in autistic brains is the result of oxidative stress [<xref ref-type="bibr" rid="B55-nutrients-12-02311">55</xref>,<xref ref-type="bibr" rid="B56-nutrients-12-02311">56</xref>]. That effect also can be related to vitamin D, which regulates the production of dendritic lymphocytes, in turn reducing the intensity of autoimmune attacks by increasing levels of interleukin 10, an anti-inflammatory cytokine [<xref ref-type="bibr" rid="B57-nutrients-12-02311">57</xref>].</p>
<p>Herein, we review the recent advances in studying the relationship between vitamin D status during the pregnancy and ASD in the outcome to try to identify the potential role of vitamin D in the etiology of ASD.</p>
</sec>
<sec id="sec2-nutrients-12-02311">
<title>2. Materials and Methods</title>
<p>To report this systematic review, we followed the guidelines specified in PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) [<xref ref-type="bibr" rid="B58-nutrients-12-02311">58</xref>,<xref ref-type="bibr" rid="B59-nutrients-12-02311">59</xref>].</p>
<sec id="sec2dot1-nutrients-12-02311">
<title>2.1. Literature Search</title>
<p>We searched the literature to identify publications eligible for inclusion in the review in the PubMed and EMBASE databases. The literature search strategy used included the keywords “pregnancy,” “gestation,” “vitamin D,” “autism,” and “autism spectrum disorder.” The search was limited to human subjects and English language articles published between 2010 and January 2020. Forty-three studies came from PubMed and 124 studies from EMBASE, for a total of 167 articles identified and retrieved. An initial screening identified 26 candidate studies. <xref ref-type="fig" rid="nutrients-12-02311-f001">Figure 1</xref> shows a PRISMA flowchart indicating the search strategy followed. After articles were assessed for eligibility, they were then identified and the first screening of the articles was performed using the information available in the abstract and result section of each study.</p>
</sec>
<sec id="sec2dot2-nutrients-12-02311">
<title>2.2. Study Inclusion/Exclusion Criteria and Data Extraction</title>
<p>We included randomized and nonrandomized controlled trials, prospective cohort studies, case-control studies, and systematic reviews on longitudinal studies that investigated how vitamin D levels during pregnancy affected the prevalence of autism in children. The selection criteria included the following:<list list-type="order"><list-item><p>Human study of vitamin D supplementation during pregnancy or vitamin D status of pregnancy or vitamin D status of ASD children;</p></list-item><list-item><p>Available information of circulation concentration of 25(OH)D in maternal blood during pregnancy or in newborn blood at birth;</p></list-item><list-item><p>Original research article and review in humans (abstracts, case reports, ecological studies, and comments were excluded);</p></list-item><list-item><p>Outcomes including incidence of autism, measures of autism, severity, measures of neurophysiological aspects of autism, or expression of autism-related genes and vitamin D during pregnancy; and</p></list-item><list-item><p>Article written in English</p><list list-type="bullet"><list-item><p>Any study between 2010 and January 2020.</p></list-item></list></list-item></list></p>
<p>Any study that involved children with any other disease that could affect serum vitamin D levels was excluded. Only publications meeting all criteria were included in this analysis. After a full assessment of the potentially relevant studies, 14 were proposed to be included in this systematic review.</p>
</sec>
<sec id="sec2dot3-nutrients-12-02311">
<title>2.3. Study Quality</title>
<p>We evaluated the methodological quality (risk of bias) of studies by using the Newcastle–Ottawa Scale (NOS) for observational studies [<xref ref-type="bibr" rid="B60-nutrients-12-02311">60</xref>,<xref ref-type="bibr" rid="B61-nutrients-12-02311">61</xref>]. The NOS criteria included (1) subject selection, 0–4; (2) comparability of subject, 0–2; and (3) clinical outcome, 0–3. Total NOS scores range from 0 (lowest) to 9 (highest). On the basis of NOS scores, studies can be divided into low quality (0–6) and high quality (7–9). Two evaluators conducted the NOS assessment independently. Any discrepancy on NOS scores of potential studies was resolved through discussion or consultation with a third evaluator.</p>
<p>For a more detailed evaluation of the selected articles, the scale proposed by the Scottish Intercollegiate Guidelines Network (SIGN) was used, establishing levels of evidence (<xref ref-type="table" rid="nutrients-12-02311-t001">Table 1</xref>) and recommendations (<xref ref-type="table" rid="nutrients-12-02311-t002">Table 2</xref>) [<xref ref-type="bibr" rid="B62-nutrients-12-02311">62</xref>]. The SIGN system yields a detailed assessment of the degree of scientific evidence. Epistemological strength is the way the articles are classified. Only the strongest evidence gives way to strong recommendations, whereas weaker evidence can give rise only to weak recommendations. The SIGN system emphasizes that studies with a high rate of bias may lead to biased results, and the bias level of the studies is determined with that system. The risk of bias and study design are used to allow assessment of the level of evidence and the quality of scientific evidence provided. When the numbers 1, 2, 3, and 4 are used to grade the study, ++, +, and −- signs are used to indicate the risk of bias. On the basis of that assessment of the quality of evidence in the articles, they are classified best to worst according to grades A, B, C, and D. That scale rating is constructed on the principles of evidence-based medicine—an approach that ensures the use of the most up-to-date, reliable, and scientifically solid evidence available in making decisions about a particular situation being studied [<xref ref-type="bibr" rid="B63-nutrients-12-02311">63</xref>].</p>
<p>We also focused on the internal validity of the studies analyzed. The factors that influence internal validity that were considered are a sample size that was large enough and that inclusion and assessment criteria were specified.</p>
</sec>
</sec>
<sec id="sec3-nutrients-12-02311" sec-type="results">
<title>3. Results</title>
<sec id="sec3dot1-nutrients-12-02311">
<title>3.1. Study Characteristics</title>
<p>The chosen studies were analyzed according to study design, location, participant, sample size, target population, and major findings. <xref ref-type="table" rid="nutrients-12-02311-t003">Table 3</xref> and <xref ref-type="table" rid="nutrients-12-02311-t004">Table 4</xref> summarize the characteristics of the studies.</p>
<p>In total, 167 articles were initially assessed in this study. After removing 29 duplicated articles, we screened 138 by their abstracts. Twenty-six articles were retrieved for full-text assessment. Finally, 14 articles from nine countries met the inclusion criteria [<xref ref-type="bibr" rid="B30-nutrients-12-02311">30</xref>,<xref ref-type="bibr" rid="B31-nutrients-12-02311">31</xref>,<xref ref-type="bibr" rid="B32-nutrients-12-02311">32</xref>,<xref ref-type="bibr" rid="B64-nutrients-12-02311">64</xref>,<xref ref-type="bibr" rid="B65-nutrients-12-02311">65</xref>,<xref ref-type="bibr" rid="B66-nutrients-12-02311">66</xref>,<xref ref-type="bibr" rid="B67-nutrients-12-02311">67</xref>,<xref ref-type="bibr" rid="B68-nutrients-12-02311">68</xref>,<xref ref-type="bibr" rid="B69-nutrients-12-02311">69</xref>,<xref ref-type="bibr" rid="B70-nutrients-12-02311">70</xref>,<xref ref-type="bibr" rid="B71-nutrients-12-02311">71</xref>,<xref ref-type="bibr" rid="B72-nutrients-12-02311">72</xref>,<xref ref-type="bibr" rid="B73-nutrients-12-02311">73</xref>,<xref ref-type="bibr" rid="B74-nutrients-12-02311">74</xref>]. The studies included 10 original research and 4 review studies conducted between 2012 and 2020.</p>
<p>The original research studies used data from five countries: China [<xref ref-type="bibr" rid="B31-nutrients-12-02311">31</xref>,<xref ref-type="bibr" rid="B32-nutrients-12-02311">32</xref>], Sweden [<xref ref-type="bibr" rid="B30-nutrients-12-02311">30</xref>,<xref ref-type="bibr" rid="B64-nutrients-12-02311">64</xref>,<xref ref-type="bibr" rid="B65-nutrients-12-02311">65</xref>], the Netherlands [<xref ref-type="bibr" rid="B66-nutrients-12-02311">66</xref>,<xref ref-type="bibr" rid="B67-nutrients-12-02311">67</xref>], Spain [<xref ref-type="bibr" rid="B68-nutrients-12-02311">68</xref>], and Australia [<xref ref-type="bibr" rid="B69-nutrients-12-02311">69</xref>]. Data from one study were obtained from neighboring states, across the United States, Canada, and Israel [<xref ref-type="bibr" rid="B70-nutrients-12-02311">70</xref>]. The review research studies included data from the United States, Australia, Sweden, China, United Kingdom, Spain, Denmark, the Netherlands, Vietnam, the Republic of Seychelles, India, Greece, Egypt, Brazil, Turkey, Qatar, Saudi Arabia, Asia, and Europe [<xref ref-type="bibr" rid="B71-nutrients-12-02311">71</xref>,<xref ref-type="bibr" rid="B72-nutrients-12-02311">72</xref>,<xref ref-type="bibr" rid="B73-nutrients-12-02311">73</xref>,<xref ref-type="bibr" rid="B74-nutrients-12-02311">74</xref>].</p>
</sec>
<sec id="sec3dot2-nutrients-12-02311">
<title>3.2. Original Research Studies</title>
<p>Chen and colleagues [<xref ref-type="bibr" rid="B31-nutrients-12-02311">31</xref>] have shown that mothers in the autistic group had significantly lower maternal serum levels of 25(OH)D than in neurotypical groups, with 55.9% and 29.4% being vitamin D deficient, respectively. Lower first-trimester maternal serum levels of 25(OH)D were associated with a significantly increased risk of developing autism in offspring (<italic>p</italic> &lt; 0.001). Fernell and colleagues [<xref ref-type="bibr" rid="B65-nutrients-12-02311">65</xref>] analyzed 25(OH)D in 58 Sweden-born sibling pairs, in which one child had ASD and the other did not. The collapsed group of children with ASD had significantly lower vitamin D levels than their siblings. The findings suggest that low prenatal vitamin D may act as a risk factor for ASD (<italic>p</italic> = 0.013). Stubb and colleagues [<xref ref-type="bibr" rid="B70-nutrients-12-02311">70</xref>] published an open-label prospective study in 2016, prescribing vitamin D during pregnancy to the expectant mothers of children with autism at a dose of 5000 IU/day. The newborn children were monitored for 3 years, during which they were assessed for autism at 18 and 36 months of age. The final outcome was that 1 of 19 (5%) developed autism in contrast to the overall recurrence rate of approximately 20%, which is evident across the literature (<italic>n</italic> = 20).</p>
<p>Vinkhuyzen and colleagues [<xref ref-type="bibr" rid="B66-nutrients-12-02311">66</xref>] in their study based on a Rotterdam birth cohort (<italic>n</italic> = 4334), found that individuals in the 25(OH)D-deficient group at midgestation had more than a twofold increased risk of ASD than the 25(OH)D-sufficient group (<italic>p</italic> = 0.03). Also, in another study conducted by Vinkhuyzen and colleagues [<xref ref-type="bibr" rid="B67-nutrients-12-02311">67</xref>] in 2018, they aimed to determine the relationship between vitamin D deficiency in pregnancy and Social Responsiveness Scale (SRS) status of their children (<italic>n</italic> = 4229). 25(OH)D concentration was measured in serum and was measured from two samples with the first sample taken at 20.6 weeks and the second sample collected at birth, from neonatal cord blood. The 25(OH)D-deficient group had significantly higher (<italic>p</italic> &lt; 0.001) (more abnormal) SRS scores than the 25(OH)D-sufficient group [25(OH)D &gt; 50 nmol/L]. Those study results serve to clarify the relationship between maternal vitamin D deficiency and offspring risk of ASD with and without intellectual disability.</p>
<p>The Stockholm Youth Cohort is a registry-based total population study (<italic>N</italic> = 509,639) [<xref ref-type="bibr" rid="B64-nutrients-12-02311">64</xref>] in which maternal vitamin D deficiency, defined as a lifetime-recorded diagnosis of unspecified vitamin D deficiency (ICD-10</p>
<p>E55.9 or ICD-9 268.9) corresponding to a serum 25-hydroxyvitamin D level of less than 25 nmol/L, was associated with offspring risk of ASD with, but not without, intellectual disability. In a 2019 study, Lee and colleagues [<xref ref-type="bibr" rid="B30-nutrients-12-02311">30</xref>] found that neonatal 25(OH)D &lt;25 nmol/L was associated with 1.33 times higher odds of ASD (95% confidence interval (CI), 1.02 to 1.75) than for levels of 25(OH)D ≥50 nmol/L. In Nordic-born mothers, maternal 25(OH)D insufficiency (25 to &lt;50 nmol/L) at ~11 weeks’ gestation was associated with 1.58 times higher odds of ASD (95% CI, 1.00 to 2.49) than for 25(OH)D sufficiency (≥50 nmol/L). Wu and colleagues [<xref ref-type="bibr" rid="B32-nutrients-12-02311">32</xref>] analyzed the concentration of 25(OH)D<sub>3</sub> in children with ASD, and controls were assessed from neonatal dried blood samples. The median 25(OH)D<sub>3</sub> level was significantly (<italic>p</italic> &lt; 0.0001) lower in children with ASD than for controls. As a result, neonatal vitamin D status was significantly associated with the risk of ASDs and intellectual disability.</p>
<p>A 2019 study [<xref ref-type="bibr" rid="B68-nutrients-12-02311">68</xref>] clearly showed that vitamin D deficiency during critical periods of pregnancy development could lead to persistent brain alterations in the fetus. Maternal plasma vitamin D<sub>3</sub> was measured in pregnancy through a single maternal blood sample at a mean of 13.3 weeks of gestation, with findings that per each 10-ng/mL increment of maternal vitamin D<sub>3</sub>, children obtained higher social competence scores at 5 years old (coefficient = 0.77; 95% CI, 0.19 to 1.35). Also, in a cohort study by Whitehouse and colleagues [<xref ref-type="bibr" rid="B69-nutrients-12-02311">69</xref>], offspring of mothers with low 25(OH)D concentrations (&lt;49 nmol/L) at 18 weeks of gestation showed increased risk for “high” scores (≥2 standard deviations above the mean) on the Attention Switching subscale.</p>
</sec>
<sec id="sec3dot3-nutrients-12-02311">
<title>3.3. Review and Meta-Analysis Studies</title>
<p>Diverse studies have investigated the impact of prenatal exposure to vitamin D levels on brain development and autism. A systematic review and meta-analysis published in 2019 [<xref ref-type="bibr" rid="B71-nutrients-12-02311">71</xref>] summarized evidence of the association between 25(OH)D levels in maternal blood in pregnancy or newborn blood at birth and neurodevelopmental outcomes. Those outcomes included cognition, psychomotor performance, language development, behavioral difficulties, attention deficit–hyperactivity disorder (ADHD), and autistic traits. That meta-analysis offers supporting evidence that increased prenatal exposure to 25(OH)D levels is associated with improved cognitive development and reduced risk of ADHD and autism-related traits later in life. Furthermore, an alternative review [<xref ref-type="bibr" rid="B72-nutrients-12-02311">72</xref>] showed that depending on the timing of the exposure to low vitamin D status, different brain areas might be affected, possibly causing different neurodevelopment and cognitive outcomes in infants. In agreement with other studies, Kočovská and colleagues and Wang and colleagues [<xref ref-type="bibr" rid="B73-nutrients-12-02311">73</xref>,<xref ref-type="bibr" rid="B74-nutrients-12-02311">74</xref>] showed that decreased vitamin D levels during pregnancy and decreased exposure to solar UVB might increase the risk for ASD.</p>
</sec>
<sec id="sec3dot4-nutrients-12-02311">
<title>3.4. Summary of Findings</title>
<p>Vitamin D plays many roles in various processes in the human body. Supporting findings from the past 15 years have come from animal studies, human molecular, cellular and physiological, genetic, and neurodevelopmental studies. And vitamin D deficiency during pregnancy or early childhood has been suggested as a possible environmental risk factor for ASD.</p>
<p>Our literature review identified many observational studies, but few intervention trials have been conducted that investigate the relationship between vitamin D level and ASD during pregnancy. The strength of evidence that vitamin D levels during pregnancy increase the risk of developing autism is very low. That evidence exclusively relies on observational studies that did not equally consider all important confounders and that assessed the indirect relationship between vitamin D as a surrogate for sunlight exposure and autism risk.</p>
<p>Despite the limited and inconclusive results of meta-analyses, research has established that early exposure to inadequate vitamin D may interact with other factors and contribute to the etiology of autism, and individuals with ASD may be a population at risk of vitamin D deficiency/inadequacy. Therefore, evidence-based clinical recommendations are needed to prevent ASD and manage ASD symptoms. Until better data are available, vitamin D is worth considering as a potential preventive measure for ASD.</p>
</sec>
</sec>
<sec id="sec4-nutrients-12-02311" sec-type="discussion">
<title>4. Discussion</title>
<p>ASD, a complex, heterogeneous neurodevelopmental disorder, had an estimated prevalence of ~1% in children in 2017 [<xref ref-type="bibr" rid="B75-nutrients-12-02311">75</xref>]. ASD is associated with biological and environmental factors. Epigenetic mechanisms have detected that gene–environment interactions are important in mediating risk [<xref ref-type="bibr" rid="B76-nutrients-12-02311">76</xref>,<xref ref-type="bibr" rid="B77-nutrients-12-02311">77</xref>].</p>
<p>ASD and low vitamin D are commonly interrelated, and children with ASD also have vitamin D deficiencies. Vitamin D deficiency affects ~1 billion people globally and is a potential environmental risk factor for ASD [<xref ref-type="bibr" rid="B43-nutrients-12-02311">43</xref>]. Epidemiological studies and data obtained in humans have yielded evidence that a mother’s diet during pregnancy plays a vital role in the development of the neural circuitry that regulates behavior, thus determining persistent behavioral effects in the offspring [<xref ref-type="bibr" rid="B78-nutrients-12-02311">78</xref>]. Generally, vitamin D concentration during pregnancy is associated with a higher or lower incidence of ASD or autistic traits in offspring [<xref ref-type="bibr" rid="B79-nutrients-12-02311">79</xref>]. A 2013 report [<xref ref-type="bibr" rid="B36-nutrients-12-02311">36</xref>] emphasized that people with low activity of vitamin D enzymes and people with maternal or early childhood vitamin D deficiency would have low activity in the vitamin D system, which is important for brain development. In addition, through several feasible mechanisms, vitamin D can help children with autism.</p>
<p>Considering whether prenatal vitamin D deficiency is associated with the development of ASD seems reasonable. The findings suggest that autistic children have lover 25(OH) D levels than their unaffected siblings [<xref ref-type="bibr" rid="B67-nutrients-12-02311">67</xref>,<xref ref-type="bibr" rid="B80-nutrients-12-02311">80</xref>]. That finding emphasizes that more randomized controlled trials are needed. But until new studies are completed, it seems prudent to maximize vitamin D levels in pregnant and lactating women, infants, and young children, as the Endocrine Society recommends, aiming for levels found in humans living in a sun-rich environment (46 ng/mL) [<xref ref-type="bibr" rid="B67-nutrients-12-02311">67</xref>,<xref ref-type="bibr" rid="B80-nutrients-12-02311">80</xref>].</p>
<p>Furthermore, nutritional quality control in the mother’s diet during pregnancy is a potentially effective strategy to prevent autism in the offspring. Nutritional deficiencies can be prevented by using safe and easily accessible supplements. That effect is seen in the results of our review, which show that using the right amount of vitamin D during pregnancy may reduce the risk of ASD [<xref ref-type="bibr" rid="B81-nutrients-12-02311">81</xref>]. Currently it is suggested that all pregnant women maintain a circulating 25(OH)D concentration of at least 40 ng/mL for the first 16 weeks of gestation [<xref ref-type="bibr" rid="B82-nutrients-12-02311">82</xref>] and to achieve this, intakes of at least 4000 IU/d vitamin D3 would be necessary [<xref ref-type="bibr" rid="B83-nutrients-12-02311">83</xref>,<xref ref-type="bibr" rid="B84-nutrients-12-02311">84</xref>]. Supplementation could be especially important in women with children diagnosed with ASD as previous studies have suggested that supplementation could reduce the recurrence rate of autism in siblings [<xref ref-type="bibr" rid="B65-nutrients-12-02311">65</xref>,<xref ref-type="bibr" rid="B70-nutrients-12-02311">70</xref>,<xref ref-type="bibr" rid="B85-nutrients-12-02311">85</xref>]. However, while the results of these studies are promising, these are preliminary studies with small sample sizes. Therefore, in order to adequately inform recommendations for mothers with children diagnosed with ASD, further research in larger samples is needed to confirm the results as well as to determine appropriate dosage.</p>
<p>By contrast, in a study that included maternal vitamin D levels, no relationship was apparent between maternal vitamin D level and autism. That study reported that no relationship existed between maternal vitamin D levels and autism in children of both white and Somali mothers [<xref ref-type="bibr" rid="B86-nutrients-12-02311">86</xref>], but fewer than 20 mothers were included in each group and analyses were performed several years after birth. A review in January 2020 concluded that vitamin D deficiency in the data available now does not adequately support the hypothesis that it may contribute to the etiology of ASD [<xref ref-type="bibr" rid="B87-nutrients-12-02311">87</xref>].</p>
<p>Future epidemiological studies should include prenatal or neonatal vitamin D levels and have enough statistical power to show convincing evidence of a relationship between low neonatal vitamin D status and the risk of autism.</p>
<sec>
<title>Strengths and Limitations of This Review</title>
<p>The clinical trials included in our analysis show significant differences in sample size, use of reinforcements, and follow-up. In addition, researchers may not be able to access all publications on the relationship between vitamin D and autism during pregnancy because the area of analysis is limited to studies published in English and available through the PubMed and EMBASE databases. However, the main outcome measured was common in all the studies and included the risk/incidence of autism/ASD in offspring.</p>
</sec>
</sec>
<sec id="sec5-nutrients-12-02311" sec-type="conclusions">
<title>5. Conclusions</title>
<p>The findings of this systematic review are consistent with the hypothesis that low vitamin D levels might contribute to the development of autism. However, we also must recognize the possibility of confusion bias because a diet with adequate levels of vitamin D is usually also adequate in other micronutrients. Experimental studies that allow us to detect blood levels in pregnant women would therefore be helpful to clarify that point. However, we must bear in mind that doing so would require a design with very large sample sizes given the incidence of autism. Further studies examining the relationship between vitamin D and autism risk are needed.</p>
</sec>
</body>
<back>
<notes>
<title>Author Contributions</title>
<p>Conceptualization, N.U., I.P.-C., M.M.S.-V.; methodology, N.U., W.B.G., I.P.-C., M.M.S.-V.; formal analysis, N.U., W.B.G., I.P.-C., M.M.S.-V.; investigation, N.U., W.B.G., I.P.-C., M.M.S.-V.; data curation, N.U., I.P.-C.; writing—original draft preparation, N.U., W.B.G., I.P.-C., M.M.S.-V.; writing—review and editing, N.U., W.B.G., I.P.-C., M.M.S.-V.; supervision, M.M.S.-V. All authors have read and agreed to the published version of the manuscript.</p>
</notes>
<notes>
<title>Funding</title>
<p>This research received no external funding.</p>
</notes>
<notes notes-type="COI-statement">
<title>Conflicts of Interest</title>
<p>The authors declare no conflict of interest.</p>
</notes>
<ref-list>
<title>References</title>
<ref id="B1-nutrients-12-02311">
<label>1.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>American Psychiatric Association</collab>
</person-group>
<source/>Diagnostic and Statistical Manual of Mental Disorders
          <publisher-name>DSM-V</publisher-name>
<publisher-loc>Washington, DC, USA</publisher-loc>
<year>2013</year>
</element-citation>
</ref>
<ref id="B2-nutrients-12-02311">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bakken</surname>
<given-names>T.E.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sunkin</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Szafer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Dalley</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Royall</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Lemon</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>A Comprehensive Transcriptional Map of Primate Brain Development</article-title>
<source/>Nature
          <year>2016</year>
<volume>535</volume>
<fpage>367</fpage>
<lpage>375</lpage>
<pub-id pub-id-type="doi">10.1038/nature18637</pub-id>
<pub-id pub-id-type="pmid">27409810</pub-id>
</element-citation>
</ref>
<ref id="B3-nutrients-12-02311">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zablotsky</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Black</surname>
<given-names>L.I.</given-names>
</name>
<name>
<surname>Maenner</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Schieve</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Blumberg</surname>
<given-names>S.J.</given-names>
</name>
</person-group>
<article-title>Estimated Prevalence of Autism and Other Developmental Disabilities Following Questionnaire Changes in the 2014 National Health Interview Survey</article-title>
<source/>Natl. Health. Stat. Rep.
          <year>2015</year>
<volume>87</volume>
<fpage>1</fpage>
<lpage>20</lpage>
</element-citation>
</ref>
<ref id="B4-nutrients-12-02311">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>Centers for Disease Control and Prevention</collab>
</person-group>
<article-title>Prevalence of Autism Spectrum Disorders-Autism and Developmental Disabilities Monitoring Network, United State, 2006</article-title>
<source/>MMWR Surveill. Summ.
          <year>2009</year>
<volume>58</volume>
<fpage>1</fpage>
<lpage>20</lpage>
</element-citation>
</ref>
<ref id="B5-nutrients-12-02311">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>Centers for Disease Control and Prevention</collab>
</person-group>
<article-title>Prevalence of Autism Spectrum Disorder among Children Aged 8 Years—Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014</article-title>
<source/>MMWR Surveill. Summ.
          <year>2018</year>
<volume>67</volume>
<fpage>1</fpage>
<lpage>23</lpage>
<pub-id pub-id-type="doi">10.15585/mmwr.ss6706a1</pub-id>
<pub-id pub-id-type="pmid">29701730</pub-id>
</element-citation>
</ref>
<ref id="B6-nutrients-12-02311">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sandin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lichtenstein</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kuja-Halkola</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hultman</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Larsson</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Reichenberg</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>The Heritability of Autism Spectrum Disorder</article-title>
<source/>JAMA
          <year>2017</year>
<volume>318</volume>
<fpage>1182</fpage>
<lpage>1184</lpage>
<pub-id pub-id-type="doi">10.1001/jama.2017.12141</pub-id>
<pub-id pub-id-type="pmid">28973605</pub-id>
</element-citation>
</ref>
<ref id="B7-nutrients-12-02311">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lai</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lombardo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Baron-Cohen</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Autism</article-title>
<source/>Lancet
          <year>2014</year>
<volume>383</volume>
<fpage>896</fpage>
<lpage>910</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(13)61539-1</pub-id>
<pub-id pub-id-type="pmid">24074734</pub-id>
</element-citation>
</ref>
<ref id="B8-nutrients-12-02311">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Magnusson</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Rai</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Goodman</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lundberg</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Idring</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Svensson</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Koupil</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Serlachius</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Dalman</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Migration and Autism Spectrum Disorder: Population-Based Study</article-title>
<source/>Br. J. Psychiatry
          <year>2012</year>
<volume>201</volume>
<fpage>109</fpage>
<lpage>115</lpage>
<pub-id pub-id-type="doi">10.1192/bjp.bp.111.095125</pub-id>
<pub-id pub-id-type="pmid">22361019</pub-id>
</element-citation>
</ref>
<ref id="B9-nutrients-12-02311">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hallmayer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cleveland</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Torres</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Phillips</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Torigoe</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Fedele</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Genetic Heritability and Shared Environmental Factors among Twin Pairs with Autism</article-title>
<source/>Arch. Gen. Psychiatry
          <year>2011</year>
<volume>68</volume>
<fpage>1095</fpage>
<lpage>1102</lpage>
<pub-id pub-id-type="doi">10.1001/archgenpsychiatry.2011.76</pub-id>
<pub-id pub-id-type="pmid">21727249</pub-id>
</element-citation>
</ref>
<ref id="B10-nutrients-12-02311">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Folstein</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rutter</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Infantile Autism: A Genetic Study of 21 Twin Pairs</article-title>
<source/>J. Child Psychol. Psychiatry
          <year>1977</year>
<volume>18</volume>
<fpage>297</fpage>
<lpage>321</lpage>
<pub-id pub-id-type="doi">10.1111/j.1469-7610.1977.tb00443.x</pub-id>
<pub-id pub-id-type="pmid">562353</pub-id>
</element-citation>
</ref>
<ref id="B11-nutrients-12-02311">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bailey</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Le Couteur</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gottesman</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Bolton</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Simonoff</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Yuzda</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Rutter</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Autism as a Strongly Genetic Disorder: Evidence from a British Twin Study</article-title>
<source/>Psychol. Med.
          <year>1995</year>
<volume>25</volume>
<fpage>63</fpage>
<lpage>77</lpage>
<pub-id pub-id-type="doi">10.1017/S0033291700028099</pub-id>
<pub-id pub-id-type="pmid">7792363</pub-id>
</element-citation>
</ref>
<ref id="B12-nutrients-12-02311">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schaaf</surname>
<given-names>C.P.</given-names>
</name>
<name>
<surname>Zoghbi</surname>
<given-names>H.Y.</given-names>
</name>
</person-group>
<article-title>Solving the Autism Puzzle a Few Pieces at a Time</article-title>
<source/>Neuron
          <year>2011</year>
<volume>70</volume>
<fpage>806</fpage>
<lpage>808</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2011.05.025</pub-id>
<pub-id pub-id-type="pmid">21658575</pub-id>
</element-citation>
</ref>
<ref id="B13-nutrients-12-02311">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>DeVilbiss</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Gardner</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Newschaffer</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>B.K.</given-names>
</name>
</person-group>
<article-title>Maternal Folate Status as a Risk Factor for Autism Spectrum Disorders: A Review of Existing Evidence</article-title>
<source/>Br. J. Nutr.
          <year>2015</year>
<volume>114</volume>
<fpage>663</fpage>
<lpage>672</lpage>
<pub-id pub-id-type="doi">10.1017/S0007114515002470</pub-id>
<pub-id pub-id-type="pmid">26243379</pub-id>
</element-citation>
</ref>
<ref id="B14-nutrients-12-02311">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bala</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Doğan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kaba</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mutluer</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Aslan</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Doğan</surname>
<given-names>S.Z.</given-names>
</name>
</person-group>
<article-title>Hormone Disorder and Vitamin Deficiency in Attention Deficit Hyperactivity Disorder (ADHD) and Autism Spectrum Disorders (ASDs)</article-title>
<source/>J. Pediatric Endocrinol. Metab.
          <year>2016</year>
<volume>29</volume>
<fpage>1077</fpage>
<lpage>1082</lpage>
<pub-id pub-id-type="doi">10.1515/jpem-2015-0473</pub-id>
<pub-id pub-id-type="pmid">27544717</pub-id>
</element-citation>
</ref>
<ref id="B15-nutrients-12-02311">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kardas</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bayram</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Demirci</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Akin</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ozmen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kendirci</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Canpolat</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Oztop</surname>
<given-names>D.B.</given-names>
</name>
<name>
<surname>Narin</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Gumus</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Increased Serum Phthalates (MEHP, DEHP) and Bisphenol a Concentrations in Children with Autism Spectrum Disorder: The Role of Endocrine Disruptors in Autism Etiopathogenesis</article-title>
<source/>J. Child Neurol.
          <year>2016</year>
<volume>31</volume>
<fpage>629</fpage>
<lpage>635</lpage>
<pub-id pub-id-type="doi">10.1177/0883073815609150</pub-id>
<pub-id pub-id-type="pmid">26450281</pub-id>
</element-citation>
</ref>
<ref id="B16-nutrients-12-02311">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skalny</surname>
<given-names>A.V.</given-names>
</name>
<name>
<surname>Skalnaya</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>Bjørklund</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Nikonorov</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Tinkov</surname>
<given-names>A.A.</given-names>
</name>
</person-group>
<article-title>Mercury as a Possible Link between Maternal Obesity and Autism Spectrum Disorder</article-title>
<source/>Med. Hypotheses
          <year>2016</year>
<volume>91</volume>
<fpage>90</fpage>
<lpage>94</lpage>
<pub-id pub-id-type="doi">10.1016/j.mehy.2016.04.021</pub-id>
<pub-id pub-id-type="pmid">27142153</pub-id>
</element-citation>
</ref>
<ref id="B17-nutrients-12-02311">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bromley</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>The Treatment of Epilepsy in Pregnancy: The Neurodevelopmental Risks Associated with Exposure to Antiepileptic Drugs</article-title>
<source/>Reprod. Toxicol.
          <year>2016</year>
<volume>64</volume>
<fpage>203</fpage>
<lpage>210</lpage>
<pub-id pub-id-type="doi">10.1016/j.reprotox.2016.06.007</pub-id>
<pub-id pub-id-type="pmid">27312074</pub-id>
</element-citation>
</ref>
<ref id="B18-nutrients-12-02311">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaplan</surname>
<given-names>Y.C.</given-names>
</name>
<name>
<surname>Keskin-Arslan</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Acar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sozmen</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Prenatal Selective Serotonin Reuptake Inhibitor use and the Risk of Autism Spectrum Disorder in Children: A Systematic Review and Meta-Analysis</article-title>
<source/>Reprod. Toxicol.
          <year>2016</year>
<volume>66</volume>
<fpage>31</fpage>
<lpage>43</lpage>
<pub-id pub-id-type="doi">10.1016/j.reprotox.2016.09.013</pub-id>
<pub-id pub-id-type="pmid">27667009</pub-id>
</element-citation>
</ref>
<ref id="B19-nutrients-12-02311">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Estes</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>McAllister</surname>
<given-names>A.K.</given-names>
</name>
</person-group>
<article-title>Maternal Immune Activation: Implications for Neuropsychiatric Disorders</article-title>
<source/>Science
          <year>2016</year>
<volume>353</volume>
<fpage>772</fpage>
<lpage>777</lpage>
<pub-id pub-id-type="doi">10.1126/science.aag3194</pub-id>
<pub-id pub-id-type="pmid">27540164</pub-id>
</element-citation>
</ref>
<ref id="B20-nutrients-12-02311">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Shao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Ling</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ruan</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Maternal Infection during Pregnancy and Risk of Autism Spectrum Disorders: A Systematic Review and Meta-Analysis</article-title>
<source/>Brain Behav. Immun.
          <year>2016</year>
<volume>58</volume>
<fpage>165</fpage>
<lpage>172</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbi.2016.06.005</pub-id>
<pub-id pub-id-type="pmid">27287966</pub-id>
</element-citation>
</ref>
<ref id="B21-nutrients-12-02311">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Offit</surname>
<given-names>P.A.</given-names>
</name>
</person-group>
<article-title>Vaccines and Autism in Primate Model</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2015</year>
<volume>112</volume>
<fpage>12236</fpage>
<lpage>12237</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1516574112</pub-id>
<pub-id pub-id-type="pmid">26417097</pub-id>
</element-citation>
</ref>
<ref id="B22-nutrients-12-02311">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodgers</surname>
<given-names>A.B.</given-names>
</name>
<name>
<surname>Morgan</surname>
<given-names>C.P.</given-names>
</name>
<name>
<surname>Bronson</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Revello</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bale</surname>
<given-names>T.L.</given-names>
</name>
</person-group>
<article-title>Paternal Stress Exposure Alters Sperm microRNA Content and Reprograms Offspring HPA Stress Axis Regulation</article-title>
<source/>J. Neurosci.
          <year>2013</year>
<volume>33</volume>
<fpage>9003</fpage>
<lpage>9012</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.0914-13.2013</pub-id>
<pub-id pub-id-type="pmid">23699511</pub-id>
</element-citation>
</ref>
<ref id="B23-nutrients-12-02311">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szachta</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Skonieczna-Żydecka</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Adler</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Karakua-Juchnowicz</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Madlani</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ignyś</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Immune Related Factors in Pathogenesis of Autism Spectrum Disorders</article-title>
<source/>Eur. Rev. Med. Pharmacol. Sci.
          <year>2016</year>
<volume>20</volume>
<fpage>3060</fpage>
<lpage>3072</lpage>
<pub-id pub-id-type="pmid">27460736</pub-id>
</element-citation>
</ref>
<ref id="B24-nutrients-12-02311">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Rodzinka-Pasko</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Environmental Risk Factors for Autism Spectrum Disorders</article-title>
<source/>Nervenarzt
          <year>2016</year>
<volume>87</volume>
<fpage>55</fpage>
<lpage>61</lpage>
<pub-id pub-id-type="doi">10.1007/s00115-016-0172-3</pub-id>
<pub-id pub-id-type="pmid">27531204</pub-id>
</element-citation>
</ref>
<ref id="B25-nutrients-12-02311">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>F.B.</given-names>
</name>
<name>
<surname>David</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>van Dam</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Bralley</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<article-title>Maternal Plasma 25-Hydroxyvitamin D Concentrations and the Risk for Gestational Diabetes Mellitus</article-title>
<source/>PLoS ONE
          <year>2008</year>
<volume>3</volume>
<elocation-id>e3753</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0003753</pub-id>
<pub-id pub-id-type="pmid">19015731</pub-id>
</element-citation>
</ref>
<ref id="B26-nutrients-12-02311">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sacks</surname>
<given-names>K.N.</given-names>
</name>
<name>
<surname>Friger</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shoham-Vardi</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Abokaf</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Spiegel</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Sergienko</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Landau</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Sheiner</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Prenatal Exposure to Gestational Diabetes Mellitus as an Independent Risk Factor for Long-Term Neuropsychiatric Morbidity of the Offspring</article-title>
<source/>Obstet. Gynecol.
          <year>2016</year>
<volume>215</volume>
<fpage>380</fpage>
</element-citation>
</ref>
<ref id="B27-nutrients-12-02311">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Curran</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>O’Neill</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Kenny</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>T.G.</given-names>
</name>
<name>
<surname>Khashan</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Kearney</surname>
<given-names>P.M.</given-names>
</name>
</person-group>
<article-title>Research Review: Birth by Caesarean Section and Development of Autism Spectrum Disorder and Attention-deficit/Hyperactivity Disorder: A Systematic Review and Meta-analysis</article-title>
<source/>J. Child Psychol. Psychiatry
          <year>2015</year>
<volume>56</volume>
<fpage>500</fpage>
<lpage>508</lpage>
<pub-id pub-id-type="doi">10.1111/jcpp.12351</pub-id>
<pub-id pub-id-type="pmid">25348074</pub-id>
</element-citation>
</ref>
<ref id="B28-nutrients-12-02311">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Merewood</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mehta</surname>
<given-names>S.D.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>T.C.</given-names>
</name>
<name>
<surname>Bauchner</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Holick</surname>
<given-names>M.F.</given-names>
</name>
</person-group>
<article-title>Association between Vitamin D Deficiency and Primary Cesarean Section</article-title>
<source/>J. Clin. Endocrinol. Metab.
          <year>2009</year>
<volume>94</volume>
<fpage>940</fpage>
<lpage>945</lpage>
<pub-id pub-id-type="doi">10.1210/jc.2008-1217</pub-id>
<pub-id pub-id-type="pmid">19106272</pub-id>
</element-citation>
</ref>
<ref id="B29-nutrients-12-02311">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grant</surname>
<given-names>W.B.</given-names>
</name>
<name>
<surname>Soles</surname>
<given-names>C.M.</given-names>
</name>
</person-group>
<article-title>Epidemiologic Evidence for Supporting the Role of Maternal Vitamin D Deficiency as a Risk Factor for the Development of Infantile Autism</article-title>
<source/>Derm. Endocrinol.
          <year>2009</year>
<volume>1</volume>
<fpage>223</fpage>
<lpage>228</lpage>
<pub-id pub-id-type="doi">10.4161/derm.1.4.9500</pub-id>
</element-citation>
</ref>
<ref id="B30-nutrients-12-02311">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>B.K.</given-names>
</name>
<name>
<surname>Eyles</surname>
<given-names>D.W.</given-names>
</name>
<name>
<surname>Magnusson</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Newschaffer</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>McGrath</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Kvaskoff</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ko</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Dalman</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Karlsson</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Gardner</surname>
<given-names>R.M.</given-names>
</name>
</person-group>
<article-title>Developmental Vitamin D and Autism Spectrum Disorders: Findings from the Stockholm Youth Cohort</article-title>
<source/>Mol. Psychiatry
          <year>2019</year>
<fpage>1</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="doi">10.1038/s41380-019-0578-y</pub-id>
</element-citation>
</ref>
<ref id="B31-nutrients-12-02311">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Xin</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Lower Maternal Serum 25 (OH) D in First Trimester Associated with Higher Autism Risk in Chinese Offspring</article-title>
<source/>J. Psychosom. Res.
          <year>2016</year>
<volume>89</volume>
<fpage>98</fpage>
<lpage>101</lpage>
<pub-id pub-id-type="doi">10.1016/j.jpsychores.2016.08.013</pub-id>
<pub-id pub-id-type="pmid">27663117</pub-id>
</element-citation>
</ref>
<ref id="B32-nutrients-12-02311">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhuang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Relationship between Neonatal Vitamin D at Birth and Risk of Autism Spectrum Disorders: The NBSIB Study</article-title>
<source/>J. Bone Miner. Res.
          <year>2018</year>
<volume>33</volume>
<fpage>458</fpage>
<lpage>466</lpage>
<pub-id pub-id-type="doi">10.1002/jbmr.3326</pub-id>
<pub-id pub-id-type="pmid">29178513</pub-id>
</element-citation>
</ref>
<ref id="B33-nutrients-12-02311">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Brook</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Leukefeld</surname>
<given-names>C.G.</given-names>
</name>
<name>
<surname>De La Rosa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Brook</surname>
<given-names>D.W.</given-names>
</name>
</person-group>
<article-title>Season of Birth: A Predictor of ADHD Symptoms in Early Midlife</article-title>
<source/>Psychiatry Res.
          <year>2018</year>
<volume>267</volume>
<fpage>243</fpage>
<lpage>248</lpage>
<pub-id pub-id-type="doi">10.1016/j.psychres.2018.05.056</pub-id>
<pub-id pub-id-type="pmid">29940455</pub-id>
</element-citation>
</ref>
<ref id="B34-nutrients-12-02311">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boland</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Parhi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Miotto</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Carroll</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Iqbal</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Schuemie</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>You</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Uncovering Exposures Responsible for Birth Seasonâ€“disease Effects: A Global Study</article-title>
<source/>J. Am. Med Inform. Assoc.
          <year>2018</year>
<volume>25</volume>
<fpage>275</fpage>
<lpage>288</lpage>
<pub-id pub-id-type="doi">10.1093/jamia/ocx105</pub-id>
<pub-id pub-id-type="pmid">29036387</pub-id>
</element-citation>
</ref>
<ref id="B35-nutrients-12-02311">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shalev</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Solt</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Chodick</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Month of Birth and Risk of Autism Spectrum Disorder: A Retrospective Cohort of Male Children Born in Israel</article-title>
<source/>BMJ Open
          <year>2017</year>
<volume>7</volume>
<fpage>014606</fpage>
<pub-id pub-id-type="doi">10.1136/bmjopen-2016-014606</pub-id>
</element-citation>
</ref>
<ref id="B36-nutrients-12-02311">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cannell</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Grant</surname>
<given-names>W.B.</given-names>
</name>
</person-group>
<article-title>What is the Role of Vitamin D in Autism</article-title>
<source/>Derm. Endocrinol.
          <year>2013</year>
<volume>5</volume>
<fpage>199</fpage>
<lpage>204</lpage>
<pub-id pub-id-type="doi">10.4161/derm.24356</pub-id>
</element-citation>
</ref>
<ref id="B37-nutrients-12-02311">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cannell</surname>
<given-names>J.J.</given-names>
</name>
</person-group>
<article-title>Autism and Vitamin D</article-title>
<source/>Med. Hypotheses
          <year>2008</year>
<volume>70</volume>
<fpage>750</fpage>
<lpage>759</lpage>
<pub-id pub-id-type="doi">10.1016/j.mehy.2007.08.016</pub-id>
<pub-id pub-id-type="pmid">17920208</pub-id>
</element-citation>
</ref>
<ref id="B38-nutrients-12-02311">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wagner</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Hollis</surname>
<given-names>B.W.</given-names>
</name>
<name>
<surname>Kotsa</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Fakhoury</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Karras</surname>
<given-names>S.N.</given-names>
</name>
</person-group>
<article-title>Vitamin D Administration during Pregnancy as Prevention for Pregnancy, Neonatal and Postnatal Complications</article-title>
<source/>Rev. Endocr. Metab. Disord.
          <year>2017</year>
<volume>18</volume>
<fpage>307</fpage>
<lpage>322</lpage>
<pub-id pub-id-type="doi">10.1007/s11154-017-9414-3</pub-id>
<pub-id pub-id-type="pmid">28214921</pub-id>
</element-citation>
</ref>
<ref id="B39-nutrients-12-02311">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karras</surname>
<given-names>S.N.</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Castracane</surname>
<given-names>V.D.</given-names>
</name>
</person-group>
<article-title>Understanding Vitamin D Metabolism in Pregnancy: From Physiology to Pathophysiology and Clinical Outcomes</article-title>
<source/>Metabolism
          <year>2018</year>
<volume>86</volume>
<fpage>112</fpage>
<lpage>123</lpage>
<pub-id pub-id-type="doi">10.1016/j.metabol.2017.10.001</pub-id>
<pub-id pub-id-type="pmid">29066285</pub-id>
</element-citation>
</ref>
<ref id="B40-nutrients-12-02311">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karras</surname>
<given-names>S.N.</given-names>
</name>
<name>
<surname>Fakhoury</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Muscogiuri</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Grant</surname>
<given-names>W.B.</given-names>
</name>
<name>
<surname>van den Ouweland</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Colao</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Kotsa</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Maternal Vitamin D Levels during Pregnancy and Neonatal Health: Evidence to Date and Clinical Implications</article-title>
<source/>Ther. Adv. Musculoskelet. Dis.
          <year>2016</year>
<volume>8</volume>
<fpage>124</fpage>
<lpage>135</lpage>
<pub-id pub-id-type="doi">10.1177/1759720X16656810</pub-id>
<pub-id pub-id-type="pmid">27493691</pub-id>
</element-citation>
</ref>
<ref id="B41-nutrients-12-02311">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spiro</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Buttriss</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Vitamin D: An Overview of Vitamin D Status and Intake in E Urope</article-title>
<source/>Nutr. Bull.
          <year>2014</year>
<volume>39</volume>
<fpage>322</fpage>
<lpage>350</lpage>
<pub-id pub-id-type="doi">10.1111/nbu.12108</pub-id>
<pub-id pub-id-type="pmid">25635171</pub-id>
</element-citation>
</ref>
<ref id="B42-nutrients-12-02311">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saggese</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Vierucci</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Prodam</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Cardinale</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Cetin</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Chiappini</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>de’Angelis</surname>
<given-names>G.L.</given-names>
</name>
<name>
<surname>Massari</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Del Giudice</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Del Giudice</surname>
<given-names>M.M.</given-names>
</name>
</person-group>
<article-title>Vitamin D in Pediatric Age: Consensus of the Italian Pediatric Society and the Italian Society of Preventive and Social Pediatrics, Jointly with the Italian Federation of Pediatricians</article-title>
<source/>Ital. J. Pediatrics
          <year>2018</year>
<volume>44</volume>
<fpage>51</fpage>
<pub-id pub-id-type="doi">10.1186/s13052-018-0488-7</pub-id>
<pub-id pub-id-type="pmid">29739471</pub-id>
</element-citation>
</ref>
<ref id="B43-nutrients-12-02311">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holick</surname>
<given-names>M.F.</given-names>
</name>
</person-group>
<article-title>Vitamin D Deficiency</article-title>
<source/>N. Engl. J. Med.
          <year>2007</year>
<volume>357</volume>
<fpage>266</fpage>
<lpage>281</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMra070553</pub-id>
<pub-id pub-id-type="pmid">17634462</pub-id>
</element-citation>
</ref>
<ref id="B44-nutrients-12-02311">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mithal</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wahl</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Bonjour</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Burckhardt</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Dawson-Hughes</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Eisman</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Fuleihan</surname>
<given-names>G.E.</given-names>
</name>
<name>
<surname>Josse</surname>
<given-names>R.G.</given-names>
</name>
<name>
<surname>Lips</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Morales-Torres</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Global Vitamin D Status and Determinants of Hypovitaminosis D</article-title>
<source/>Osteoporos. Int.
          <year>2009</year>
<volume>20</volume>
<fpage>1807</fpage>
<lpage>1820</lpage>
<pub-id pub-id-type="doi">10.1007/s00198-009-0954-6</pub-id>
<pub-id pub-id-type="pmid">19543765</pub-id>
</element-citation>
</ref>
<ref id="B45-nutrients-12-02311">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shin</surname>
<given-names>Y.H.</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>H.J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>Y.J.</given-names>
</name>
</person-group>
<article-title>Vitamin D Status and Childhood Health</article-title>
<source/>Korean J. Pediatr.
          <year>2013</year>
<volume>56</volume>
<fpage>417</fpage>
<lpage>423</lpage>
<pub-id pub-id-type="doi">10.3345/kjp.2013.56.10.417</pub-id>
<pub-id pub-id-type="pmid">24244209</pub-id>
</element-citation>
</ref>
<ref id="B46-nutrients-12-02311">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ali</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Eyles</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Developmental Vitamin D Deficiency and Autism: Putative Pathogenic Mechanisms</article-title>
<source/>J. Steroid Biochem. Mol. Biol.
          <year>2018</year>
<volume>175</volume>
<fpage>108</fpage>
<lpage>118</lpage>
<pub-id pub-id-type="doi">10.1016/j.jsbmb.2016.12.018</pub-id>
<pub-id pub-id-type="pmid">28027915</pub-id>
</element-citation>
</ref>
<ref id="B47-nutrients-12-02311">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>DeLuca</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Kimball</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kolasinski</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ramagopalan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ebers</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>The Role of Vitamin D in Nervous System Health and Disease</article-title>
<source/>Neuropathol. Appl. Neurobiol.
          <year>2013</year>
<volume>39</volume>
<fpage>458</fpage>
<lpage>484</lpage>
<pub-id pub-id-type="doi">10.1111/nan.12020</pub-id>
<pub-id pub-id-type="pmid">23336971</pub-id>
</element-citation>
</ref>
<ref id="B48-nutrients-12-02311">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chiu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>1, 25-Dihydroxyvitamin D 3 Attenuates Endotoxin-Induced Production of Inflammatory Mediators by Inhibiting MAPK Activation in Primary Cortical Neuron-Glia Cultures</article-title>
<source/>J. Neuroinflamm.
          <year>2015</year>
<volume>12</volume>
<fpage>147</fpage>
<pub-id pub-id-type="doi">10.1186/s12974-015-0370-0</pub-id>
</element-citation>
</ref>
<ref id="B49-nutrients-12-02311">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cannell</surname>
<given-names>J.J.</given-names>
</name>
</person-group>
<article-title>Vitamin D and Autism, What’s New</article-title>
<source/>Rev. Endocr. Metab. Disord.
          <year>2017</year>
<volume>18</volume>
<fpage>183</fpage>
<lpage>193</lpage>
<pub-id pub-id-type="doi">10.1007/s11154-017-9409-0</pub-id>
<pub-id pub-id-type="pmid">28217829</pub-id>
</element-citation>
</ref>
<ref id="B50-nutrients-12-02311">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patrick</surname>
<given-names>R.P.</given-names>
</name>
<name>
<surname>Ames</surname>
<given-names>B.N.</given-names>
</name>
</person-group>
<article-title>Vitamin D Hormone Regulates Serotonin Synthesis. Part 1: Relevance for Autism</article-title>
<source/>FASEB J.
          <year>2014</year>
<volume>28</volume>
<fpage>2398</fpage>
<lpage>2413</lpage>
<pub-id pub-id-type="doi">10.1096/fj.13-246546</pub-id>
<pub-id pub-id-type="pmid">24558199</pub-id>
</element-citation>
</ref>
<ref id="B51-nutrients-12-02311">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arnson</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Itzhaky</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mosseri</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Barak</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Tzur</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Agmon-Levin</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Amital</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Vitamin D Inflammatory Cytokines and Coronary Events: A Comprehensive Review</article-title>
<source/>Clin. Rev. Allergy Immunol.
          <year>2013</year>
<volume>45</volume>
<fpage>236</fpage>
<lpage>247</lpage>
<pub-id pub-id-type="doi">10.1007/s12016-013-8356-0</pub-id>
<pub-id pub-id-type="pmid">23314982</pub-id>
</element-citation>
</ref>
<ref id="B52-nutrients-12-02311">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krakowiak</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Goines</surname>
<given-names>P.E.</given-names>
</name>
<name>
<surname>Tancredi</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Ashwood</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Hertz-Picciotto</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Van de Water</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Neonatal Cytokine Profiles Associated with Autism Spectrum Disorder</article-title>
<source/>Biol. Psychiatry
          <year>2017</year>
<volume>81</volume>
<fpage>442</fpage>
<lpage>451</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2015.08.007</pub-id>
<pub-id pub-id-type="pmid">26392128</pub-id>
</element-citation>
</ref>
<ref id="B53-nutrients-12-02311">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wrzosek</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Łukaszkiewicz</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wrzosek</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jakubczyk</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Matsumoto</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Piątkiewicz</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Radziwoń-Zaleska</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wojnar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nowicka</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Vitamin D and the Central Nervous System</article-title>
<source/>Pharmacol. Rep.
          <year>2013</year>
<volume>65</volume>
<fpage>271</fpage>
<lpage>278</lpage>
<pub-id pub-id-type="doi">10.1016/S1734-1140(13)71003-X</pub-id>
<pub-id pub-id-type="pmid">23744412</pub-id>
</element-citation>
</ref>
<ref id="B54-nutrients-12-02311">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kesby</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Eyles</surname>
<given-names>D.W.</given-names>
</name>
<name>
<surname>Burne</surname>
<given-names>T.H.</given-names>
</name>
<name>
<surname>McGrath</surname>
<given-names>J.J.</given-names>
</name>
</person-group>
<article-title>The Effects of Vitamin D on Brain Development and Adult Brain Function</article-title>
<source/>Mol. Cell. Endocrinol.
          <year>2011</year>
<volume>347</volume>
<fpage>121</fpage>
<lpage>127</lpage>
<pub-id pub-id-type="doi">10.1016/j.mce.2011.05.014</pub-id>
<pub-id pub-id-type="pmid">21664231</pub-id>
</element-citation>
</ref>
<ref id="B55-nutrients-12-02311">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smaga</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Niedzielska</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Gawlik</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Moniczewski</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Krzek</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Przegaliński</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Pera</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Filip</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Oxidative Stress as an Etiological Factor and a Potential Treatment Target of Psychiatric Disorders. Part 2. Depression, Anxiety, Schizophrenia and Autism</article-title>
<source/>Pharmacol. Rep.
          <year>2015</year>
<volume>67</volume>
<fpage>569</fpage>
<lpage>580</lpage>
<pub-id pub-id-type="doi">10.1016/j.pharep.2014.12.015</pub-id>
<pub-id pub-id-type="pmid">25933971</pub-id>
</element-citation>
</ref>
<ref id="B56-nutrients-12-02311">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cortelazzo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>De Felice</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Guerranti</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Signorini</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Leoncini</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zollo</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Leoncini</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Timperio</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Zolla</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ciccoli</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Expression and Oxidative Modifications of Plasma Proteins in Autism Spectrum Disorders: Interplay between Inflammatory Response and Lipid Peroxidation</article-title>
<source/>Proteom. Clin. Appl.
          <year>2016</year>
<volume>10</volume>
<fpage>1103</fpage>
<lpage>1112</lpage>
<pub-id pub-id-type="doi">10.1002/prca.201500076</pub-id>
<pub-id pub-id-type="pmid">27246309</pub-id>
</element-citation>
</ref>
<ref id="B57-nutrients-12-02311">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bakdash</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>van Capel</surname>
<given-names>T.M.</given-names>
</name>
<name>
<surname>Mason</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Kapsenberg</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>de Jong</surname>
<given-names>E.C.</given-names>
</name>
</person-group>
<article-title>Vitamin D3 Metabolite Calcidiol Primes Human Dendritic Cells to Promote the Development of Immunomodulatory IL-10-Producing T Cells</article-title>
<source/>Vaccine
          <year>2014</year>
<volume>32</volume>
<fpage>6294</fpage>
<lpage>6302</lpage>
<pub-id pub-id-type="doi">10.1016/j.vaccine.2014.08.075</pub-id>
<pub-id pub-id-type="pmid">25236584</pub-id>
</element-citation>
</ref>
<ref id="B58-nutrients-12-02311">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moher</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Shamseer</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ghersi</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Liberati</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Petticrew</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shekelle</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Stewart</surname>
<given-names>L.A.</given-names>
</name>
</person-group>
<article-title>Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015 Statement</article-title>
<source/>Syst. Rev.
          <year>2015</year>
<volume>4</volume>
<fpage>1</fpage>
<pub-id pub-id-type="doi">10.1186/2046-4053-4-1</pub-id>
<pub-id pub-id-type="pmid">25554246</pub-id>
</element-citation>
</ref>
<ref id="B59-nutrients-12-02311">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moher</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Liberati</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tetzlaff</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Altman</surname>
<given-names>D.G.</given-names>
</name>
</person-group>
<article-title>Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement</article-title>
<source/>Ann. Intern. Med.
          <year>2009</year>
<volume>151</volume>
<fpage>264</fpage>
<lpage>269</lpage>
<pub-id pub-id-type="doi">10.7326/0003-4819-151-4-200908180-00135</pub-id>
<pub-id pub-id-type="pmid">19622511</pub-id>
</element-citation>
</ref>
<ref id="B60-nutrients-12-02311">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stang</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Critical Evaluation of the Newcastle-Ottawa Scale for the Assessment of the Quality of Nonrandomized Studies in Meta-Analyses</article-title>
<source/>Eur. J. Epidemiol.
          <year>2010</year>
<volume>25</volume>
<fpage>603</fpage>
<lpage>605</lpage>
<pub-id pub-id-type="doi">10.1007/s10654-010-9491-z</pub-id>
<pub-id pub-id-type="pmid">20652370</pub-id>
</element-citation>
</ref>
<ref id="B61-nutrients-12-02311">
<label>61.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Wells</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Tugwell</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>O’Connell</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Welch</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Peterson</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shea</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Losos</surname>
<given-names>M.</given-names>
</name>
</person-group>
<source/>The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta-Analyses
          <publisher-name>University of Ottawa</publisher-name>
<publisher-loc>Ottawa, ON, Canada</publisher-loc>
<year>2015</year>
</element-citation>
</ref>
<ref id="B62-nutrients-12-02311">
<label>62.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>Scottish Intercollegiate Guidelines Network (SIGN)</collab>
</person-group>
<source/>SIGN 50: A Guideline Developer’s Handbook
          <publisher-name>Scottish Intercollegiate Guidelines Network</publisher-name>
<publisher-loc>Edinburgh, UK</publisher-loc>
<year>2015</year>
</element-citation>
</ref>
<ref id="B63-nutrients-12-02311">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sackett</surname>
<given-names>D.L.</given-names>
</name>
</person-group>
<article-title>Evidence-Based Medicine</article-title>
<source/>Semin. Perinatol.
          <year>1997</year>
<volume>21</volume>
<fpage>3</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="doi">10.1016/S0146-0005(97)80013-4</pub-id>
<pub-id pub-id-type="pmid">9190027</pub-id>
</element-citation>
</ref>
<ref id="B64-nutrients-12-02311">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Magnusson</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kosidou</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Dalman</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lundberg</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>B.K.</given-names>
</name>
<name>
<surname>Rai</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Karlsson</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Gardner</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Arver</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Maternal Vitamin D Deficiency and the Risk of Autism Spectrum Disorders: Population-Based Study</article-title>
<source/>BJPsych Open
          <year>2016</year>
<volume>2</volume>
<fpage>170</fpage>
<lpage>172</lpage>
<pub-id pub-id-type="doi">10.1192/bjpo.bp.116.002675</pub-id>
<pub-id pub-id-type="pmid">27703770</pub-id>
</element-citation>
</ref>
<ref id="B65-nutrients-12-02311">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fernell</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bejerot</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Westerlund</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Miniscalco</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Simila</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Eyles</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gillberg</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Humble</surname>
<given-names>M.B.</given-names>
</name>
</person-group>
<article-title>Autism Spectrum Disorder and Low Vitamin D at Birth: A Sibling Control Study</article-title>
<source/>Mol. Autism
          <year>2015</year>
<volume>6</volume>
<fpage>3</fpage>
<pub-id pub-id-type="doi">10.1186/2040-2392-6-3</pub-id>
<pub-id pub-id-type="pmid">25874075</pub-id>
</element-citation>
</ref>
<ref id="B66-nutrients-12-02311">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vinkhuyzen</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Eyles</surname>
<given-names>D.W.</given-names>
</name>
<name>
<surname>Burne</surname>
<given-names>T.H.</given-names>
</name>
<name>
<surname>Blanken</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Kruithof</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Verhulst</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>White</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Jaddoe</surname>
<given-names>V.W.</given-names>
</name>
<name>
<surname>Tiemeier</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>McGrath</surname>
<given-names>J.J.</given-names>
</name>
</person-group>
<article-title>Gestational Vitamin D Deficiency and Autism Spectrum Disorder</article-title>
<source/>BJPsych Open
          <year>2017</year>
<volume>3</volume>
<fpage>85</fpage>
<lpage>90</lpage>
<pub-id pub-id-type="doi">10.1192/bjpo.bp.116.004077</pub-id>
<pub-id pub-id-type="pmid">28446959</pub-id>
</element-citation>
</ref>
<ref id="B67-nutrients-12-02311">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vinkhuyzen</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Eyles</surname>
<given-names>D.W.</given-names>
</name>
<name>
<surname>Burne</surname>
<given-names>T.H.</given-names>
</name>
<name>
<surname>Blanken</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Kruithof</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Verhulst</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Jaddoe</surname>
<given-names>V.W.</given-names>
</name>
<name>
<surname>Tiemeier</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>McGrath</surname>
<given-names>J.J.</given-names>
</name>
</person-group>
<article-title>Gestational Vitamin D Deficiency and Autism-Related Traits: The Generation R Study</article-title>
<source/>Mol. Psychiatry
          <year>2018</year>
<volume>23</volume>
<fpage>240</fpage>
<lpage>246</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2016.213</pub-id>
<pub-id pub-id-type="pmid">27895322</pub-id>
</element-citation>
</ref>
<ref id="B68-nutrients-12-02311">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>López-Vicente</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sunyer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lertxundi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>González</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Rodríguez-Dehli</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Sáenz-Torre</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Vrijheid</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tardón</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Llop</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Torrent</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Maternal Circulating Vitamin D 3 Levels during Pregnancy and Behaviour Across Childhood</article-title>
<source/>Sci. Rep.
          <year>2019</year>
<volume>9</volume>
<fpage>1</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1038/s41598-019-51325-3</pub-id>
<pub-id pub-id-type="pmid">30626917</pub-id>
</element-citation>
</ref>
<ref id="B69-nutrients-12-02311">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Whitehouse</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Holt</surname>
<given-names>B.J.</given-names>
</name>
<name>
<surname>Serralha</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Holt</surname>
<given-names>P.G.</given-names>
</name>
<name>
<surname>Hart</surname>
<given-names>P.H.</given-names>
</name>
<name>
<surname>Kusel</surname>
<given-names>M.M.</given-names>
</name>
</person-group>
<article-title>Maternal Vitamin D Levels and the Autism Phenotype among Offspring</article-title>
<source/>J. Autism Dev. Disord.
          <year>2013</year>
<volume>43</volume>
<fpage>1495</fpage>
<lpage>1504</lpage>
<pub-id pub-id-type="doi">10.1007/s10803-012-1676-8</pub-id>
<pub-id pub-id-type="pmid">23070790</pub-id>
</element-citation>
</ref>
<ref id="B70-nutrients-12-02311">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stubbs</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Henley</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Autism: Will Vitamin D Supplementation during Pregnancy and Early Childhood Reduce the Recurrence Rate of Autism in Newborn Siblings</article-title>
<source/>Med. Hypotheses
          <year>2016</year>
<volume>88</volume>
<fpage>74</fpage>
<lpage>78</lpage>
<pub-id pub-id-type="doi">10.1016/j.mehy.2016.01.015</pub-id>
<pub-id pub-id-type="pmid">26880644</pub-id>
</element-citation>
</ref>
<ref id="B71-nutrients-12-02311">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>García-Serna</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Morales</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Neurodevelopmental Effects of Prenatal Vitamin D in Humans: Systematic Review and Meta-Analysis</article-title>
<source/>Mol. Psychiatry
          <year>2019</year>
<fpage>1</fpage>
<lpage>14</lpage>
<pub-id pub-id-type="doi">10.1038/s41380-019-0357-9</pub-id>
</element-citation>
</ref>
<ref id="B72-nutrients-12-02311">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mazahery</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Camargo</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Conlon</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Beck</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Kruger</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Von Hurst</surname>
<given-names>P.R.</given-names>
</name>
</person-group>
<article-title>Vitamin D and Autism Spectrum Disorder: A Literature Review</article-title>
<source/>Nutrients
          <year>2016</year>
<volume>8</volume>
<elocation-id>236</elocation-id>
<pub-id pub-id-type="doi">10.3390/nu8040236</pub-id>
<pub-id pub-id-type="pmid">27110819</pub-id>
</element-citation>
</ref>
<ref id="B73-nutrients-12-02311">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kočovská</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Fernell</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Billstedt</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Minnis</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Gillberg</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Vitamin D and Autism: Clinical Review</article-title>
<source/>Res. Dev. Disabil.
          <year>2012</year>
<volume>33</volume>
<fpage>1541</fpage>
<lpage>1550</lpage>
<pub-id pub-id-type="doi">10.1016/j.ridd.2012.02.015</pub-id>
<pub-id pub-id-type="pmid">22522213</pub-id>
</element-citation>
</ref>
<ref id="B74-nutrients-12-02311">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Shan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Staal</surname>
<given-names>W.G.</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Serum Concentration of 25-Hydroxyvitamin D in Autism Spectrum Disorder: A Systematic Review and Meta-Analysis</article-title>
<source/>Eur. Child Adolesc. Psychiatry
          <year>2016</year>
<volume>25</volume>
<fpage>341</fpage>
<lpage>350</lpage>
<pub-id pub-id-type="doi">10.1007/s00787-015-0786-1</pub-id>
<pub-id pub-id-type="pmid">26514973</pub-id>
</element-citation>
</ref>
<ref id="B75-nutrients-12-02311">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kerley</surname>
<given-names>C.P.</given-names>
</name>
<name>
<surname>Power</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Gallagher</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Coghlan</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Lack of Effect of Vitamin D3 Supplementation in Autism: A 20-Week, Placebo-Controlled RCT</article-title>
<source/>Arch. Dis. Child.
          <year>2017</year>
<volume>102</volume>
<fpage>1030</fpage>
<lpage>1036</lpage>
<pub-id pub-id-type="doi">10.1136/archdischild-2017-312783</pub-id>
<pub-id pub-id-type="pmid">28626020</pub-id>
</element-citation>
</ref>
<ref id="B76-nutrients-12-02311">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Newschaffer</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Falb</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Gurney</surname>
<given-names>J.G.</given-names>
</name>
</person-group>
<article-title>National Autism Prevalence Trends from United States Special Education Data</article-title>
<source/>Pediatrics
          <year>2005</year>
<volume>115</volume>
<fpage>277</fpage>
<lpage>282</lpage>
<pub-id pub-id-type="doi">10.1542/peds.2004-1958</pub-id>
<pub-id pub-id-type="pmid">15741352</pub-id>
</element-citation>
</ref>
<ref id="B77-nutrients-12-02311">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kinney</surname>
<given-names>D.K.</given-names>
</name>
<name>
<surname>Barch</surname>
<given-names>D.H.</given-names>
</name>
<name>
<surname>Chayka</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Napoleon</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Munir</surname>
<given-names>K.M.</given-names>
</name>
</person-group>
<article-title>Environmental Risk Factors for Autism: Do they Help Cause De Novo Genetic Mutations that Contribute to the Disorder</article-title>
<source/>Med. Hypotheses
          <year>2010</year>
<volume>74</volume>
<fpage>102</fpage>
<lpage>106</lpage>
<pub-id pub-id-type="doi">10.1016/j.mehy.2009.07.052</pub-id>
<pub-id pub-id-type="pmid">19699591</pub-id>
</element-citation>
</ref>
<ref id="B78-nutrients-12-02311">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wiens</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>DeSoto</surname>
<given-names>M.C.</given-names>
</name>
</person-group>
<article-title>Is High Folic Acid Intake a Risk Factor for Autism—A Review</article-title>
<source/>Brain Sci.
          <year>2017</year>
<volume>7</volume>
<elocation-id>149</elocation-id>
<pub-id pub-id-type="doi">10.3390/brainsci7110149</pub-id>
</element-citation>
</ref>
<ref id="B79-nutrients-12-02311">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peretti</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mariano</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mazzocchetti</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Mazza</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pino</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Verrotti Di Pianella</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Valenti</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Diet: The Keystone of Autism Spectrum Disorder</article-title>
<source/>Nutr. Neurosci.
          <year>2019</year>
<volume>22</volume>
<fpage>825</fpage>
<lpage>839</lpage>
<pub-id pub-id-type="doi">10.1080/1028415X.2018.1464819</pub-id>
<pub-id pub-id-type="pmid">29669486</pub-id>
</element-citation>
</ref>
<ref id="B80-nutrients-12-02311">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luxwolda</surname>
<given-names>M.F.</given-names>
</name>
<name>
<surname>Kuipers</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Kema</surname>
<given-names>I.P.</given-names>
</name>
<name>
<surname>Dijck-Brouwer</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Muskiet</surname>
<given-names>F.A.</given-names>
</name>
</person-group>
<article-title>Traditionally Living Populations in East Africa have a Mean Serum 25-Hydroxyvitamin D Concentration of 115 Nmol/L</article-title>
<source/>Br. J. Nutr.
          <year>2012</year>
<volume>108</volume>
<fpage>1557</fpage>
<lpage>1561</lpage>
<pub-id pub-id-type="doi">10.1017/S0007114511007161</pub-id>
<pub-id pub-id-type="pmid">22264449</pub-id>
</element-citation>
</ref>
<ref id="B81-nutrients-12-02311">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>DeVilbiss</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Magnusson</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Gardner</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Rai</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Newschaffer</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Lyall</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Dalman</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>B.K.</given-names>
</name>
</person-group>
<article-title>Antenatal Nutritional Supplementation and Autism Spectrum Disorders in the Stockholm Youth Cohort: Population Based Cohort Study</article-title>
<source/>BMJ
          <year>2017</year>
<volume>359</volume>
<fpage>4273</fpage>
<pub-id pub-id-type="doi">10.1136/bmj.j4273</pub-id>
</element-citation>
</ref>
<ref id="B82-nutrients-12-02311">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wagner</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Baggerly</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>McDonnell</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Baggerly</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>French</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Baggerly</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Hamilton</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hollis</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Post-Hoc Analysis of Vitamin D Status and Reduced Risk of Preterm Birth in Two Vitamin D Pregnancy Cohorts Compared with South Carolina March of Dimes 2009–2011 Rates</article-title>
<source/>J. Steroid Biochem. Mol. Biol.
          <year>2016</year>
<volume>155</volume>
<fpage>245</fpage>
<lpage>251</lpage>
<pub-id pub-id-type="doi">10.1016/j.jsbmb.2015.10.022</pub-id>
<pub-id pub-id-type="pmid">26554936</pub-id>
</element-citation>
</ref>
<ref id="B83-nutrients-12-02311">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hollis</surname>
<given-names>B.W.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hulsey</surname>
<given-names>T.C.</given-names>
</name>
<name>
<surname>Ebeling</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>C.L.</given-names>
</name>
</person-group>
<article-title>Vitamin D Supplementation during Pregnancy: Double-blind, Randomized Clinical Trial of Safety and Effectiveness</article-title>
<source/>J. Bone Miner. Res.
          <year>2011</year>
<volume>26</volume>
<fpage>2341</fpage>
<lpage>2357</lpage>
<pub-id pub-id-type="doi">10.1002/jbmr.463</pub-id>
<pub-id pub-id-type="pmid">21706518</pub-id>
</element-citation>
</ref>
<ref id="B84-nutrients-12-02311">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heaney</surname>
<given-names>R.P.</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>T.C.</given-names>
</name>
<name>
<surname>Holick</surname>
<given-names>M.F.</given-names>
</name>
<name>
<surname>Barger-Lux</surname>
<given-names>M.J.</given-names>
</name>
</person-group>
<article-title>Human Serum 25-Hydroxycholecalciferol Response to Extended Oral Dosing with Cholecalciferol</article-title>
<source/>Am. J. Clin. Nutr.
          <year>2003</year>
<volume>77</volume>
<fpage>204</fpage>
<lpage>210</lpage>
<pub-id pub-id-type="doi">10.1093/ajcn/77.1.204</pub-id>
<pub-id pub-id-type="pmid">12499343</pub-id>
</element-citation>
</ref>
<ref id="B85-nutrients-12-02311">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schmidt</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Iosif</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Angel</surname>
<given-names>E.G.</given-names>
</name>
<name>
<surname>Ozonoff</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Association of Maternal Prenatal Vitamin use with Risk for Autism Spectrum Disorder Recurrence in Young Siblings</article-title>
<source/>JAMA Psychiatry
          <year>2019</year>
<volume>76</volume>
<fpage>391</fpage>
<lpage>398</lpage>
<pub-id pub-id-type="doi">10.1001/jamapsychiatry.2018.3901</pub-id>
<pub-id pub-id-type="pmid">30810722</pub-id>
</element-citation>
</ref>
<ref id="B86-nutrients-12-02311">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fernell</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Barnevik-Olsson</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bågenholm</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Gillberg</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Gustafsson</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sääf</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Serum Levels of 25-hydroxyvitamin D in Mothers of Swedish and of Somali Origin Who have Children with and without Autism</article-title>
<source/>Acta Paediatr.
          <year>2010</year>
<volume>99</volume>
<fpage>743</fpage>
<lpage>747</lpage>
<pub-id pub-id-type="doi">10.1111/j.1651-2227.2010.01755.x</pub-id>
<pub-id pub-id-type="pmid">20219032</pub-id>
</element-citation>
</ref>
<ref id="B87-nutrients-12-02311">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Principi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Esposito</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Vitamin D Deficiency during Pregnancy and Autism Spectrum Disorders Development</article-title>
<source/>Front. Psychiatry.
          <year>2020</year>
<volume>10</volume>
<fpage>987</fpage>
<pub-id pub-id-type="doi">10.3389/fpsyt.2019.00987</pub-id>
<pub-id pub-id-type="pmid">32082196</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="nutrients-12-02311-f001" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<p>Search strategy.</p>
</caption>
<graphic xlink:href="nutrients-12-02311-g001"></graphic>
</fig>
<table-wrap id="nutrients-12-02311-t001" orientation="portrait" position="float">
<object-id pub-id-type="pii">nutrients-12-02311-t001_Table 1</object-id>
<label>Table 1</label>
<caption>
<p>Levels of evidence.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Grade</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Risk of Bias</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Description</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="3" style="border-bottom:solid thin" valign="middle">1</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">1++</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">High-quality meta-analyses, systematic reviews of RCTs, or RCTs with very low risk of bias</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">1+</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Well-conducted meta-analyses, systematic reviews of RCTs, or RCTs with low risk of bias</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">1−−</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Meta-analyses, systematic reviews, or RCTs with high risk of bias</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="3" style="border-bottom:solid thin" valign="middle">2</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2++</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">High-quality systematic reviews of case-control or cohort studies; high-quality case-control or cohort studies with very low risk of confounding or bias and high probability of casual relationship</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2+</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Well-conducted case-control or cohort studies with low risk of confounding or bias and moderate probability of casual relationship</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2−−</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Case-control or cohort studies with high risk of confounding or bias and significant risk of noncausal relationship</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">3</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Nonanalytic studies, e.g., case reports, case series</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">4</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Expert opinion</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>RCT, randomized controlled trial.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="nutrients-12-02311-t002" orientation="portrait" position="float">
<object-id pub-id-type="pii">nutrients-12-02311-t002_Table 2</object-id>
<label>Table 2</label>
<caption>
<p>Grades of recommendation.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Grade</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Description</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">A</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">At least one meta-analysis, systematic review, or RCT rated 1++, and directly applicable to target population<break></break>A body of evidence consisting principally of studies rated 1+, directly applicable to the target population, and demonstrating overall consistency of results</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">B</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">A body of evidence including studies rated 2++, directly applicable to target population, and demonstrating overall consistency of results<break></break>Extrapolated evidence from studies rated 1++ or 1+</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">C</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">A body of evidence including studies rated 2+, directly applicable to the target population, and demonstrating overall consistency of results<break></break>Extrapolated evidence from studies rated 2++</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">D</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Evidence level 3 or 4Extrapolated evidence from studies rated 2+</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="nutrients-12-02311-t003" orientation="portrait" position="float">
<object-id pub-id-type="pii">nutrients-12-02311-t003_Table 3</object-id>
<label>Table 3</label>
<caption>
<p>Original research studies on 25-hydroxyvitamin D (25(OH)D) during pregnancy and autism.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Ref.</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Location</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Study Design</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Period of Study</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Participant</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Sample Size</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Target Pop.</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Exposure Assessment Vitamin D</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Major Findings</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">LE</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">GR</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">NOS</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Wu et al. (2018) [<xref ref-type="bibr" rid="B32-nutrients-12-02311">32</xref>]</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Beijing, China</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Case-control</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2008–2010</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Newborn screening in Beijing (NBSIB)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 32,912 (<italic>n</italic> = 310 ASD and <italic>n</italic> = 1240 controls)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Children monitored from birth to age 3 years</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Tiny sample of blood; liquid chromatography–tandem mass spectrometry</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Neonatal vitamin D status was significantly (<italic>p</italic> &lt; 0.0001) associated with risk of ASDs and intellectual disability. Compared with the fourth quartiles, the RR of ASDs was significantly increased for neonates in each of the three lower quartiles of the distribution of 25(OH)D3, and increased risk of ASDs by 260% (RR for lowest quartile, 3.6; 95% CI, 1.8 to 7.2; <italic>p</italic> &lt; 0.001), 150% (RR for second quartile: 2.5; 95% CI, 1.4 to 3.5; <italic>p</italic> = 0.024), and 90% (RR for third quartile: 1.9; 95% CI, 1.1 to 3.3; <italic>p</italic> = 0.08), respectively.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2++</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">B</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">8</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">B.K. Lee et al. (2019) [<xref ref-type="bibr" rid="B30-nutrients-12-02311">30</xref>]</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Stockholm County, Sweden</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cohort</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Participants born in Sweden, 1996–2000</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Stockholm Youth Cohort (<italic>n</italic> = 98,597)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Maternal sample consisted of 449 ASD cases and 574 controls, the neonatal sample: 1399 ASD cases and 1607 controls; and the paired maternal–neonatal sample: 340 ASD cases and 426 controls</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cohort of all children aged 0–17 years living in Stockholm County</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Maternal sample examining prenatal 25(OH)D in maternal sera; neonatal sample examining neonatal 25(OH)D in dried blood spots taken soon after birth; neonatal sibling sample examining neonatal 25(OH)D in cases matched to unaffected siblings; and paired maternal–neonatal sample examining both maternal and neonatal 25(OH)D. 25(OH)D was measured using a tandem mass spectrometry assay.</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">In Nordic-born mothers, maternal 25(OH)D insufficiency (25–&lt;50 nmol/L) at ~11 weeks’ gestation was associated with 1.58 times higher odds of ASD (95% CI, 1.00 to 2.49) than 25(OH)D sufficiency (≥50 nmol/L). Neonatal 25(OH)D &lt;25 nmol/L was associated with 1.33 times higher odds of ASD (95% CI, 1.02 to 1.75) than 25(OH)D ≥50 nmol/L.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2++</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">B</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">8</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>M.L. Vicente et al. (2019)</italic> [<xref ref-type="bibr" rid="B68-nutrients-12-02311">68</xref>]</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Spain: Asturias, Gipuzkoa, Menorca, Sabadell, Valencia</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cohort</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Feb. 1997–Sept. 1998, Menorca; Nov. 2003–Feb. 2008, other regions</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Embedded in the Infancia y Medio Ambiente (INMA) Project, a population-based birth cohort based in regions across Spain</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>N</italic> = 3216; <italic>n</italic> = 2107 (mother–child pairs)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">10–13 weeks of gestation and their child’s neurodevelopmental assessment at 5, 8, 14, and 18 years old</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Maternal blood and child plasma concentrations of 25(OH)D3 by high-performance liquid chromatography method using a Bio-Rad kit according to Clinical and Laboratory Standard Institute protocols</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Per each 10-ng/mL increment of maternal vitamin D<sub>3</sub>, children obtained higher social competence scores (β-coefficient = 0.77; 95% CI, 0.19 to 1.35) at 5 y old</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">2++</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">B</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">8</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>25(OH)D, 25-hydroxyvitamin D; 95% CI, 95% confidence interval; ASD, autism spectrum disorder; GR, grade of recommendation; LE, level of evidence; NOS, Newcastle–Ottawa Scale; RR, relative risk.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="nutrients-12-02311-t004" orientation="portrait" position="float">
<object-id pub-id-type="pii">nutrients-12-02311-t004_Table 4</object-id>
<label>Table 4</label>
<caption>
<p>Review and meta-analysis studies on vitamin D during pregnancy and autism 3.2. Study Design and Population.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="2" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Ref.</th>
<th align="center" colspan="1" rowspan="2" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Design</th>
<th align="center" colspan="3" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Studies Included</th>
<th align="center" colspan="1" rowspan="2" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Location and Year</th>
<th align="center" colspan="1" rowspan="2" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Participants</th>
<th align="center" colspan="1" rowspan="2" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Sample Size (Case with ASD/Control)</th>
<th align="center" colspan="1" rowspan="2" style="border-top:solid thin;border-bottom:solid thin" valign="middle">ASD Diagnosis</th>
<th align="center" colspan="1" rowspan="2" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Findings</th>
<th align="center" colspan="1" rowspan="2" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Major Findings</th>
<th align="center" colspan="1" rowspan="2" style="border-top:solid thin;border-bottom:solid thin" valign="middle">LE</th>
<th align="center" colspan="1" rowspan="2" style="border-top:solid thin;border-bottom:solid thin" valign="middle">GR</th>
</tr>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Common</th>
<th align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Different</th>
<th align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Design</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="4" style="border-bottom:solid thin" valign="middle">E. Kocovska et al. (2012) [<xref ref-type="bibr" rid="B73-nutrients-12-02311">73</xref>]</td>
<td align="center" colspan="1" rowspan="4" style="border-bottom:solid thin" valign="middle">Review</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Humble et al. (2010)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">No controls, cross-sectional</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Sweden</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">European adults psychiatric disorder incl. autism</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>N</italic> = 117 (117/0)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Significant difference (<italic>p</italic> &lt; 0.005)<break></break>The median (25th–75th percentile) is in autistic patients, 31.5 ng/mL (23–39); and in all patients, 45 ng/mL (31–60)</td>
<td align="center" colspan="1" rowspan="4" style="border-bottom:solid thin" valign="middle">Vitamin D deficiency in pregnancy or early childhood may be an environmental trigger for ASD in people genetically susceptible to autism.</td>
<td align="center" colspan="1" rowspan="4" style="border-bottom:solid thin" valign="middle">2++</td>
<td align="center" colspan="1" rowspan="4" style="border-bottom:solid thin" valign="middle">B</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Meguid et al. (2010)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Case-control, cross-sectional</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Egypt</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Children with or without autism</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 112 (70/42)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">DSM-IV for clinical diagnosis</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Significant difference (<italic>p</italic> &lt; 0.005)<break></break>In autistic children, 28.5 ng/mL<break></break>Controls: typically developing children 40.1 ng/mL<break></break>In addition, children with autism had significantly lower 25(OH)D (<italic>p</italic> &lt; 0.00001) and 1,25(OH)(2)D (<italic>p</italic> &lt; 0.005) as well as lower calcium (<italic>p</italic> &lt; 0.0001) serum values than the controls.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Molloy et al. (2010)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Case-control, cross-sectional</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">USA</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">White male children aged 4–8 years with ASD</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 89 (49/40)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">DSM-IV/ADOS</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">No significant difference (<italic>p</italic> = 0.4)<break></break>Cases: 20 ng/mL<break></break>All Participants &lt;31 ng/mL.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Fernell et al. (2010)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Case-control, cross-sectional</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Sweden</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Mothers of Somali or Swedish origin with a child with or without autism</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 80 (40/40)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Significant difference Somali vs. Swedish mothers<break></break>Cases: Somali mothers with autism child 6.7 ng/mL;<break></break>Swedish mothers with autistic child 24.8 ng/mL<break></break>Controls: Somali mothers with nonautistic child 9.6 ng/mL; Swedish mothers with nonautistic child 20.7 ng/mL.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="7" style="border-bottom:solid thin" valign="middle">H. Mazahery et al. (2016) [<xref ref-type="bibr" rid="B72-nutrients-12-02311">72</xref>]</td>
<td align="center" colspan="1" rowspan="7" style="border-bottom:solid thin" valign="middle">Review</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Humble et al. (2010)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">No controls, cross-sectional</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Sweden</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">European adults psychiatric disorder incl. autism</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 117 (117/0)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Significant difference (<italic>p</italic> &lt; 0.005)<break></break>In autistic patients, 31.5 ng/mL (23–39)<break></break>In all patients, 45 ng/mL (31–60).</td>
<td align="center" colspan="1" rowspan="7" style="border-bottom:solid thin" valign="middle">Low vitamin D status in utero, postnatal, and early childhood might affect different brain regions, and that situation might cause different neurodevelopmental and cognitive outcomes in infants.</td>
<td align="center" colspan="1" rowspan="7" style="border-bottom:solid thin" valign="middle">2++</td>
<td align="center" colspan="1" rowspan="7" style="border-bottom:solid thin" valign="middle">B</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Stubbs et al. (2016)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Prospective cohort (uncontrolled)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">USA</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Pregnant mothers of autistic children aged 18 months–3 years</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 20 (no control)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">MCHAT and PDDBI</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Although autism recurrence rate reported in the literature is 20%, recurrence rate of autism in newborns was 5%.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Saad et al. (2015)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Open-label intervention</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Egypt</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Autistic children with 25(OH)D &lt;75 nmol/L</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 222<break></break>(122/100)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">DSM-IV/CARS, ABC <sup>2</sup></td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">13% (<italic>n</italic> = 16): normal serum 25(OH)D concentration <break></break>57% (<italic>n</italic> = 70): vitamin D deficiency, <break></break>30% (<italic>n</italic> = 36): vitamin D insufficiency<break></break>Mean 25(OH)D levels in patients with severe autism were significantly lower than patients with mild or moderate autism (<italic>p</italic> &lt; 0.0001).<break></break>Serum 25(OH)D levels showed significant negative correlation with CARS scores (<italic>r</italic> = −0.502, <italic>p</italic> &lt; 0.0001).</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Azzam HME et al. (2015)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">RCT</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Egypt;<break></break>from January 2009 until June 2010</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Children with ASD</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 21 (21/0)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">DSM-IV</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">No significant difference (three groups: 2.7 ± 1.9 y for vitamin D–supplemented group, 5.8 ± 2.9 y for unsupplemented autistic group, 5 ± 1.8 y for neurotypical control group)<break></break>Mean presupplementation CARS scores for the two autistic groups were 33.9 ± 2.9 and 33 ± 3 (<italic>p</italic> &gt; 0.05).<break></break>Mean VABS was 51.4 ± 16 and 55.7 ± 20 (<italic>p</italic> &gt; 0.05).</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Ucuz İİ et al. (2015)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Open-label intervention</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Turkey</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Toddlers aged 2–5 years with developmental delay without and with ASD</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 66; 25(OH)D &lt;50 nmol/L (<italic>n</italic> = 11 cases) and ≥50 nmol/L (<italic>n</italic> =10 controls)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">ABC <sup>1</sup> Denver II</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">No significant difference between groups with normal and low vitamin D levels in terms of ADSI, Denver II, CBCL, and ABC scores, and NGF and GDNF levels (<italic>p</italic> &gt; 0.05).</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Jia F et al. (2015)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Case</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">China</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">32-month-old male toddler with ASD</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">ABC <sup>1</sup><break></break>CARS</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Some autism symptoms improved significantly after vitamin D<sub>3</sub> supplementation.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Feng J et al. (2016)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Open-label intervention</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">China</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Children with ASD</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 500 (215/285)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">DSM-IV/ADOS</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Vitamin D3 may play an important role in etiology of ASD.<break></break>Serum levels of 25(OH)D were significantly lower in ASD children than control group (<italic>p</italic> &lt; 0.05).</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="11" style="border-bottom:solid thin" valign="middle">T. Wang et al. (2016) [<xref ref-type="bibr" rid="B74-nutrients-12-02311">74</xref>]</td>
<td align="center" colspan="1" rowspan="11" style="border-bottom:solid thin" valign="middle">Systematic review and meta-analysis</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Fernell et al. (2015)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Sibling–control</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Sweden, 2005–2008</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Gothenburg catchment area group and Stockholm Somali group; children aged 4+ years</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 116 (58/58)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Clinical report; ASD diagnosis</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Collapsed group of children with ASD had significantly lower vitamin D levels (Mean = 24.0 nM, SD = 19.6) than siblings (Mean = 31.9 nM, SD = 27.7) (<italic>p</italic> = 0.013).</td>
<td align="center" colspan="1" rowspan="11" style="border-bottom:solid thin" valign="middle">Decreased vitamin D levels in patients, decreased maternal vitamin D levels during pregnancy, and decreased exposure to solar UVB might increase the risk for ASD.</td>
<td align="center" colspan="1" rowspan="11" style="border-bottom:solid thin" valign="middle">2++</td>
<td align="center" colspan="1" rowspan="11" style="border-bottom:solid thin" valign="middle">B</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Meguid et al. (2010)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Case-control, cross-sectional</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Egypt</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Children with or without autism</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 112 (70/42)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">DSM-IV for clinical diagnosis</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Significant difference (<italic>p</italic> &lt; 0.005)<break></break>In autistic children, 28.5 ng/mL<break></break>Controls: typically developing children 40.1 ng/mL<break></break>In addition, children with autism had significantly lower 25(OH)D (<italic>p</italic> &lt; 0.00001) and 1,25(OH)(2)D (<italic>p</italic> &lt; 0.005) as well as lower calcium (<italic>p</italic> &lt; 0.0001) serum values than the controls.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Saad et al. (2015)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Open-label intervention</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Egypt</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Children with ASD</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 222 (122/100)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">DSM-IV/CARS, ABC <sup>2</sup></td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">13% (<italic>n</italic> = 16): normal serum 25(OH)D concentration <break></break>57% (<italic>n</italic> = 70): vitamin D deficiency, <break></break>30% (<italic>n</italic> = 36): vitamin D insufficiency<break></break>Mean 25(OH)D levels in patients with severe autism were significantly lower than patients with mild or moderate autism (<italic>p</italic> &lt; 0.0001).<break></break>Serum 25(OH)D levels showed significant negative correlation with CARS scores (<italic>r</italic> = −0.502, <italic>p</italic> &lt; 0.0001).</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Adams et al. (2011)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Randomized, double-blind, placebo-controlled</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">U.S.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Two groups, an Arizona group aged 5–16 years and a National group aged 3–60 y; children and adults with autism</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 141 (53/88)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">DSM-V</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">No significant differences between ASD and control group in vitamin D<sub>3</sub><break></break>[25(OH)D in plasma; <italic>p</italic> = 0.04].</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Mostafa et al. (2012)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cross-sectional</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Saudi Arabia, April–September 2012</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Children aged 5–12 years<break></break>with and without ASD</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 80 (50/30)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">DSM-IV</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Autistic children had significantly lower serum levels of 25(OH)D than healthy children (<italic>p</italic> &lt; 0.001).<break></break>In addition, serum 25(OH)D levels had significant negative correlations with CARS (<italic>p</italic> &lt; 0.001) and serum levels of anti-MAG autoantibodies (<italic>p</italic> &lt; 0.001).</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Neumeyer et al. (2013)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cohort</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">U.S.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Boys aged 8–14 years with and without ASD</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 37 (18/19)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">DSM-IV</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Serum 25(OH)D levels were lower in boys with ASD than in controls (<italic>p</italic> = 0.05).</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Uğur et al. (2014)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Case-control</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Turkey</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">ASD (recruited for the study); non-ASD healthy controls</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 108 (54/54)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">DSM-IV</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">No difference between ASD and healthy controls.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Gong et al. (2014)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Case-control</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">China, January–December 2012</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Children with and without ASD; consecutive patients with ASD admitted to Dept. of Neurology</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 96 (48/48)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">DSM-IV, CARS (all cases)</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Significant negative association between serum 25(OH)D levels and CARS scores (<italic>p</italic> = 0.000).</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Bener et al. (2014)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Case-control</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Qatar, June 2011–May 2013</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Children aged 3–8 years; children with and without ASD</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 508 (254/254)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">DSM-IV</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Significant difference found in mean values of vitamin D between autism (18.39 ± 8.2 ng/mL with median 18) and versus control children (21.59 ± 8.4 ng/mL) (<italic>p</italic> &lt; 0.0001) and with median 21 (<italic>p</italic> = 0.004).</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">DU et al. (2015)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cohort</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">China</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Children with and without ASD</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 226 (117/109)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Lower 25(OH)D in ASD group (<italic>p</italic> &lt; 0.01).</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Tostes et al. (2012)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cohort</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Brazil</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Children with and without ASD</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 48 (24/24)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">DSM-IV</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Serum levels of 25(OH)D were lower in children with autism (26.48 ± 3.48 ng/mL) than in typically developing subjects (40.52 ± 3.13 ng/mL) (<italic>p</italic> &lt; 0.001).</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="25" style="border-bottom:solid thin" valign="middle">A.M. Garcia-Serna and E. Morales (2019) [<xref ref-type="bibr" rid="B71-nutrients-12-02311">71</xref>]</td>
<td align="center" colspan="1" rowspan="25" style="border-bottom:solid thin" valign="middle">Systematic review and meta-analysis</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Stubbs et al. (2016)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Prospective cohort (uncontrolled)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">U.S.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Pregnant mothers of autistic children; 18 months–3 years</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 20 (no control)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">MCHAT and PDDBI</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Although the autism recurrence rate reported in the literature is 20%, the recurrence rate of autism in newborns was 5%.</td>
<td align="center" colspan="1" rowspan="25" style="border-bottom:solid thin" valign="middle">Meta-analysis showed higher levels of prenatal 25(OH)D to be associated with a lower risk of autistic traits.</td>
<td align="center" colspan="1" rowspan="25" style="border-bottom:solid thin" valign="middle">2++</td>
<td align="center" colspan="1" rowspan="25" style="border-bottom:solid thin" valign="middle">B</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Fernell et al. (2015)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Sibling–control</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Sweden, 2005–2008</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Gothenburg catchment area group and Stockholm Somali group; children aged 4+ years</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 116 (58/58)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Clinical report; ASD</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Collapsed group of children with ASD had significantly lower vitamin D levels (M = 24.0 nM, SD = 19.6) than their siblings (M = 31.9 nM, SD = 27.7) (<italic>p</italic> = 0.013).</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Morales et al. (2012)<break></break></td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cohort</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Spain, 2003–2008</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Mothers (13 weeks) 25(OH)D; children aged 14 months</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 1820</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Psychologist report; BSID</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Infants of mothers with 25(OH)D3 concentrations in pregnancy &gt;30 ng/mL showed higher mental score (β = 2.60; 95% CI, 0.63 to 4.56) and higher psychomotor score (β = 2.32; 95% CI, 0.36 to 4.28) than those of mothers with 25(OH)D<sub>3</sub> concentrations &lt;20 ng/mL.<break></break>The median plasma value of 25(OH)D (3) in pregnancy was 29.6 ng/mL (interquartile range, 21.8–37.3).</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Morales et al. (2015)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cohort</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Spain; 1997–2008</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Mothers (13 weeks) 25(OH)D; children aged 4–8 years</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 1650</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">DSM-IV</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Total ADHD-like symptoms in children decreased by 11% per 10-ng/mL increment of maternal 25(OH)D3 concentration (IRR = 0.89; 95% CI, 0.80 to 0.98).<break></break>Similarly, number of symptoms in the ADHD subscales decreased in relation to higher maternal 25(OH)D3 concentration (IRR per 10-ng/mL increment = 0.89; 95% CI, 0.79 to 0.99 for inattention scale; and IRR = 0.88; 95% CI, 0.78 to 0.99 for hyperactivity-impulsivity scale).<break></break>Using diagnostic criteria, researchers found that association of increasing maternal 25(OH)D3 with a lower risk of ADHD DSM-IV (relative risk ratio per 10-ng/mL increment = 0.87; 95% CI, 0.72, 1.06) and ICD-10 hyperkinetic disorder (relative risk ratio = 0.72; 95% CI, 0.49, 1.04) in children.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Zhu et al. (2015)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cohort</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">China, 2008</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Children aged 16–18 months</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 363</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Certified examiners; BSID</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Toddlers in lowest quintile of cord blood 25(OH)D exhibited a deficit of 7.60 (95% CI, 212.4 to 22.82; <italic>p</italic> = 0.002) and 8.04 (95% CI, 212.9 to 23.11; <italic>p</italic> = 0.001) points in the MDI and PDI scores, respectively, compared with the reference category.<break></break>Mean 25(OH)D (range): 4.9 (2.2–44.4).</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Chen et al. (2016)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Case-control</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">China, January 2014–December 2015</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Mothers (1st trimester) 25(OH)D; children aged 3–7 years</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 136 (68/68)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">DSM-V</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Mothers in autistic group had significantly lower maternal serum levels of 25(OH) D than in typically developing group [19.2 (IQR: 15.8–22.9) ng/mL vs. 24.3 (19.3–27.3) ng/mL, <italic>p</italic> &lt; 0.001] with 55.9% and 29.4% being vitamin D deficient, respectively (<italic>p</italic> &lt; 0.001).<break></break>Levels of 25(OH) D increased with decreasing severity of ASD as defined by CARS score (<italic>r</italic> = −0.302, <italic>p</italic> &lt; 0.001).<break></break>Maternal first-trimester serum levels of 25(OH)D in the lower 3 quartiles (quartile 1, 2, 3) (compared to the highest quartile) were associated with increased odds of ASD diagnosis in offspring [OR (95% CI) Q1: 1.36 (0.84 to 2.58, <italic>p</italic> = 0.25); Q2: 2.68 (1.44 to 4.29, <italic>p</italic> = 0.006); Q3: 3.99 (2.58 to 7.12, <italic>p</italic> &lt; 0.001)].</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Magnusson et al. (2016)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cohort</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Sweden, 2001–2011</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Stockholm Youth Cohort; Swedish-born individuals aged 4–17 years (no control)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>N</italic> = 509,639 (9882 ASD cases; 2476 with intellectual disability, 7406 without intellectual disability)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">National and regional registers; ASD diagnosis</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Maternal vitamin D deficiency was associated with offspring risk of ASD with, but not without, intellectual disability (aORs 2.51; 95% CI, 1.22 to 5.16 and 1.28, 95% CI, 0.68 to 2.42).</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Darling et al. (2017)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cohort</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">UK, 1991–1992</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Mothers (29 weeks) 25(OH)D; children aged 6–42 months; 7–9 years</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 7065</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Maternal report; SDQ</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Children of vitamin D–deficient mothers (&lt;50.0 nmol/L) were more likely to have scores in the lowest quartile for gross motor development at 30 months (OR 1.20; 95% CI, 1.03 to 1.40), fine-motor development at 30 months (OR 1.23; 95% CI, 1.05 to 1.44), and social development at 42 months (OR 1.20; 95% CI; 1.01 to 1.41) than vitamin D–sufficient mothers (≥50.0 nmol/L).<break></break>Median (IQR) 25(OH)D: 24.5 (17.2–33.9).</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Chawla et al. (2017)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Prospective</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">U.S., 2009–2011</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Newborn Epigenetic Study; mothers who measured 25(OH)D concn in plasma samples in first or second trimester; children aged 12–24 months</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 218 mother–infant pairs</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Maternal report; ITSEA</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Black mothers had much lower 25(OH)D concentrations than white and Hispanic mothers.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Gould et al. (2017)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">RCT of DHA supplementation in pregnancy</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Australia;<break></break>2005–2008</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Children aged 18 months–4 years</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">299–323</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Psychologist report; BSID-III</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">25(OH)D was not associated with cognitive, motor, social-emotional or adaptive behavior scores at 18 months or cognitive score at age 4 years.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Laird et al. (2017)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cohort</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Republic of Seychelles, 2001</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Mothers 25(OH)D; children aged 5 years</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 189</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">CBCL; total <italic>t</italic> score</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Maternal 25(OH)D concentrations were not associated with child anthropometric or neurodevelopmental outcomes. <break></break>Mean (SD) 25(OH)D: 22.4 (11.4) ng/ml</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Mossin et al. 2017)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cohort</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Denmark, 2010–2012</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Newborns (cord blood) 25(OH)D; children aged 1.5–5 y</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 1233</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Parental report; CBCL; ADHD score</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cord blood 25(OH)D levels &gt; 25 nmol/L and &gt;30 nmol/L were associated with lower attention deficit hyperactivity disorder scores than levels = 25 nmol/L or &lt;25 nmol/L (<italic>p</italic> = 0.035) and =30 nmol/L or &lt;30 nmol/L (<italic>p</italic> = 0.043), respectively.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Daraki et al. (2018)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cohort</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Greece, 2006–2007</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Mothers (13 weeks) 25(OH)D; children aged 4 y</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 487</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">SDQ</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Children of mothers with high 25(OH)D levels had also fewer total behavioral difficulties (β-coeff: −1.25, 95% CI, −2.32, to –0.19) and externalizing symptoms (β-coeff: −0.87, 95% CI to −1.58, −0.15) at preschool age.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Vinkhuyzen et al. (2017)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cohort</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Netherlands, April 2002 and January 2006</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Embedded in the Generation R Study; mothers (mid-gestation) 25(OH)D; children aged 6 y</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 3895, <italic>n</italic> = 2870</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Clinical records; ASD diagnosis</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Individuals in the 25(OH)D-deficient group at mid-gestation had more than twofold increased risk of ASD (OR = 2.42, 95% CI, 1.09 to 5.07, <italic>p</italic> = 0.03) compared with the 25(OH)D-sufficient group.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Vinkhuyzen et al. (2018)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Prospective cohort</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Netherlands, April 2002 and January 2006</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Embedded in the Generation R Study; mothers (mid gestation) 25(OH)D; children aged 6 y</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 4229</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Parental report; SRS: autism-related traits</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Compared with the 25OHD sufficient group (25OHD &gt;50 nmol/L), those who were 25(OH)D deficient had significantly higher (more abnormal) SRS scores (mid- gestation <italic>n</italic> = 2866, β = 0.06, <italic>p</italic> &lt; 0.001; cord blood <italic>n</italic> = 1712, β = 0.03, <italic>p</italic> = 0.01).</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Wang et al. (2018)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cohort</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">China, 2012–2013</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Newborns (cord blood) 25(OH)D; children aged 2 y</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 552</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Parental report; ASQ: gross and fine-motor skills</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Median of the 25(OH)D concentration in cord blood was 22.4 ng/mL (IQR, 27.3–8.6). Infants born in winter had lower 25(OH)D concentration. 25(OH)D deficiency was not associated with weight <italic>z</italic>-score (mean difference, 0.07; 95% CI, −0.09 to 0.23), length <italic>z</italic>-score (mean difference, 0.01; 95% CI, −0.19 to 0.21), head circumference <italic>z</italic>-score (mean difference, −0.06; 95% CI, −0.27 to 0.15) and BMI <italic>z</italic>-score (mean difference, 0.09; 95% CI, −0.07 to 0.25) or neurodevelopment during infancy, adjusting for sex, socioeconomic position, prepregnancy maternal BMI, and maternal and neonatal characteristics.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Veena et al. (2017)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cohort</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">India, 1997–1998</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Mothers (30 weeks) 25(OH)D; children aged 9–10 and 13–14 y</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 468; <italic>n</italic> = 472</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Psychologist report; KABC</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">No evidence of an association between maternal vitamin D status and offspring cognitive function.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Tylavsky et al. (2015)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cohort</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">U.S., 2006–2011</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">CANDLE Study<break></break>Mothers (2nd trimester) 25(OH)D; children aged 2 years</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 1020 mother; 16–28 weeks of gestation</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">BSID</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Gestational 25(OH)D was positively associated with cognitive scaled scores, receptive language, and expressive language (<italic>p</italic> &lt; 0.001)<break></break>Mean (range) 25(OH)D: 22.3 (5.9–68.4) ng/ml</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Gale et al. (2008)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cohort</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">UK (Southampton), 1991–1992</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Mothers (32 weeks) 25(OH)D; children aged 9 y</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 178</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Mother report; SDQ</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">No statistically significant associations between maternal 25(OH)D concn and full-scale, verbal or performance IQ, assessed by the Wechsler Abbreviated Scale of Intelligence (<italic>p</italic> &gt; 0.005)<break></break>Median (IQR) 25(OH)D:25 (15–30.1) ng/ml</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Hanieh et al. (2014)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cohort</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Vietnam, 2010–2012</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Mothers (32 weeks) 25(OH)D; children aged 6 months</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 960</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Psychologist report; BSID</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Infants born to women with 25(OH)D deficiency (&lt;37.5 nmol/L) had lower developmental language scores than infants born to women who were vitamin D replete (≥75 nmol/L) (mean difference, −3.48; 95% CI, −5.67 to –1.28).</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Whitehouse et al. (2012)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cohort</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Perth, Western Australia, 1989–1991</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Mothers (18 weeks) 25(OH)D; children aged 2–17 y</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">412–652</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Parental report; CBCL: total behavior, internalizing behavior, externalizing behavior</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">No significant associations between maternal 25(OH)D serum quartiles and offspring behavioral/emotional problems at any age.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Whitehouse et al. (2013)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cohort</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Australia, May 1989 and Nov. 1991</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Raine Study Mothers gestational age 16–20 wks; children aged 5–17 y</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 406</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Parental report; ASD diagnosis; autism spectrum quotient</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Offspring of mothers with low 25(OH)D concentrations (&lt;49 nmol/L) were at increased risk for “high” scores (≥2 SD above mean) on the Attention Switching subscale (OR, 5.46; 95% CI, 1.29 to 23.05).</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Strøm et al. (2014)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cohort</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Denmark, <break></break>1988–1989</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Mothers (&gt;30 weeks) 25(OH)D; children aged 22 y</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 850</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Population-based registry; prescription for medication or hospital admission for: ADHD</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Direct association between maternal vitamin D status and offspring depression<break></break>(<italic>p</italic><sub>trend</sub> = 0.01).</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Gustafsson et al. (2015)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Cohort</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Sweden, 1978–2000</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Newborns (cord blood) 25(OH)D3; children aged 5–17 y</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><italic>n</italic> = 404 (202/202)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">DSM-III-R used before 1994 and DSM-IV used after 1994</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">No differences in cord blood vitamin D concentration were found between children with ADHD (median 13.0 ng/mL) and controls (median 13.5 ng/mL) (<italic>p</italic> = 0.43).</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Keim et al. (2014)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Case-control</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">U.S., 1959–1965</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Collaborative Perinatal Project; <italic>n</italic> = 55,000 pregnant women; children aged 8 month and 4–7 y</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">3146–3587</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Psychologist report; BSID</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">IQ at age 7 was associated with both maternal and cord blood 25(OH)D (β for 5-nmol/L increment of maternal 25(OH)D = 0.10; 95% CI, 0.00 to 0.19).</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>ASD, autism spectrum disorder; RCT, randomized controlled trial; 95% CI, 95% confidence interval; ABC <sup>1</sup>, Autism Behavior Checklist; ABC <sup>2</sup>, Aberrant Behaviour Checklist; ADHD, Attention deficit–hyperactivity disorder; ADOS, Autism Diagnostic Observation Schedule; aOR, Adjusted odds ratio; ASQ, Ages and Stages Questionnaire; BMI, body mass index (kilograms per square meter of body surface area); BSID, Bayley Scales of Infant Development; CARS, Childhood Autism Rating Scale; CBCL, Child Behavior Checklist; DSM, Diagnostic and Statistical Manual; GDNF, glial cell line–derived neurotrophic factor; IQR, interquartile range; IRR, incidence rate ratio; ITSEA, Infant–Toddler Social and Emotional Assessment; KABC, Kaufmann Assessment Battery for Children; anti-MAG, anti- myelin-associated glycoprotein; DHA, docosahexaenoic acid; MCHAT, Modified Checklist for Autism in Toddlers; MDI, mental development index; NGF, nerve growth factor; OR, odds ratio; PDDBI, Pervasive Developmental Disorder Behavior Inventory; PDI, Psychomotor development index; SDQ, Strengths and Difficulties Questionnaire; SD, standard deviation; SRS, Social Responsiveness Scale.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</floats-group>
</article>
</pmc-articleset>